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ABSTRACT  
 
The paper studies how internationalization is perceived to drive innovation within the MNC 
context. Much has been investigated about the connection between both concepts, yet a 
significant amount of literature has focused on the role of innovation as a driver of 
internationalization. After identifying this investigative pattern, the study seeks to broaden 
the current research scope by exploring the reverse relationship. The empirical study adopted 
a qualitative approach, where a multiple case study was conducted through semi – structured 
interviews.  
 
From a theoretical standpoint, a comprehensive literature review has been conducted 
concerning the concepts of internationalization and innovation, both of which have been key 
elements in the expansion of current business practice and literature. The paper goes on to 
investigate what academia has found regarding how the former drives the latter. Further, 
from an empirical angle, the study makes a contribution to existing literature by conducting 
a detailed research about innovation and internationalization within Puerto Rico’s 
pharmaceutical industry, focusing on internationalization – related factors that are perceived 
to influence its innovation. Finally, an analysis of the data is conducted and conclusions 
based on the studied empirical contributions are presented. Throughout the paper, several 
elements are identified as essential within the studied relationship, particularly knowledge, 
made evident throughout the theoretical and empirical findings.  
 
_________________________________________________________________________ 
KEYWORDS: internationalization, innovation, pharmaceutical industry, Puerto Rico, 
knowledge. 
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1. INTRODUCTION 
 
 
1.1. Background of the study 
 
 
The development and evolution of the international economy has introduced important 
changes regarding the interaction amongst economic agents and the factors determining the 
conditions of competition (Fletcher 2001). This has resulted in an increase in the 
interconnectedness and interdependence of firms and in a greater participation of such firms 
in the global economy. Propelling these changes, internationalization and innovation have 
become two particularly growing themes (Rogers 2004).   
 
Internationalization and innovation have transformed the business environment and have 
contributed to the creation and advancement of unique opportunities that many firms exploit 
in order to stay competitive. The current global changes in the economy require firms to 
broaden their focus past domestic markets and seek opportunities at an international level. 
As established by several authors, in today’s challenging environment, businesses grow 
either by launching new products and/or services (innovation), by entering new markets and 
attracting new customers (internationalization), or by adopting a combination of both 
strategies (Kyläheiko et al. 2011; Denicolai et al. 2015).  
 
Both internationalization and innovation have been key in the expansion of current 
international business literature, and researchers and scholars have made significant 
contributions regarding their roles. The breadth of perspectives vary, but a significant 
number of authors have extended the research spectrum and stipulated their pertinence in 
the continuous development and growth of companies. Some consider them as two of the 
most important factors determining business success (Buckler and Zien 1996; Wind and 
Mahajan 1997; Zahra and George 2002; Vila and Kuster 2007). Denicolai et al. (2015) 
establish that internationalization and innovation “play a vital role in today’s competitive 
business environment and both are considered to be key drivers of firm performance.”  
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Research has established that a cumulative causal relationship between internationalization 
and innovation exists (Filippetti et al. 2013), meaning that both factors influence each other. 
However, significant academic attention has been given to the role innovation plays as a 
driver of firm internationalization (Posner 1961; Hufbauer 1966; Vernon 1966; Amendola 
et al. 1993; Cantwell 1989; Cantwell and Sanna Randaccio 1993; Krugman 1995; 
Fageberger 1996; Murray and Ron 2010; Filippetti et al. 2013; Veglio and Zuchella 2015). 
This one – sided relationship has been thoroughly explored and discussed in literature, and 
significant insights have been proposed. As established by previous work, innovation drives 
internationalization because “product, process and managerial innovations can support 
international growth” (Veglio and Zuchella 2015). However, throughout the investigation, 
it was identified that not so much emphasis has been put on the reverse relationship: how 
internationalization drives innovation. Identifying this opportunity in research, the aim of 
this study is to explore and explain how internationalization drives innovation within the 
multinational corporation (MNC) context. Particularly, the study aims to contribute to 
existing literature by conducting an empirical research about how this relationship takes 
place within Puerto Rico’s pharmaceutical industry.  
 
 
1.2. Research questions and objectives 
 
 
The aim of this study is to explore and explain how internationalization drives innovation. 
To conduct the empirical research, the paper will study how this takes place within Puerto 
Rico’s pharmaceutical industry.  
 
The research questions (RQs) are formulated in the following ways: 
 
RQ 1: What do innovation and internationalization mean within Puerto Rico’s 
pharmaceutical industry?  
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RQ 2: How is internationalization perceived to drive innovation within Puerto Rico’s 
pharmaceutical industry? 
 
The paper will take a deeper look into the existing theory explaining the relationship between 
internationalization and innovation, seeking to study how the former drives the latter in a 
broad, multinational context. In furtherance of applying the theoretical findings to a real 
international business setting, an empirical study will be conducted within Puerto Rico’s 
pharmaceutical industry.  
 
Theoretical objective: 
 
TRO: Thoroughly explore the concepts of innovation and internationalization, taking a 
deeper look into the literature explaining the relationship between both concepts. 
 
Empirical objectives: 
 
ERO 1: Explore the concepts of innovation and internationalization within the context of 
Puerto Rico’s pharmaceutical industry. 
 
ERO 2: Explain the perceived ways in which internationalization drives innovation within 
Puerto Rico’s pharmaceutical industry. 
 
 
1.3. Scope and delimitations of the study 
 
 
While the connection between internationalization and innovation is often considered causal 
(Filippetti et al. 2013), literature has focused primarily on exploring the influence of 
innovation on the internationalization of firms (Posner 1961; Hufbauer 1966; Vernon 1966; 
Amendola et al. 1993; Cantwell 1989; Cantwell and Sanna Randaccio 1993; Krugman 1995; 
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Fageberger 1996; Murray and Ron 2010; Filippetti et al. 2013; Veglio and Zuchella 2015). 
As established by Castaño et al. 2015, innovation makes products more competitive, either 
in terms of technology, price, or both. In this way, they state that through innovation, 
products are able to expand to more markets. However, while this innovation – 
internationalization relationship has been widely covered in literature, this paper aims to 
contribute to existing literature by going deeper into the other side of the relationship: how 
internationalization drives innovation. This research focus is based on the understanding 
that internationalization provides firms with favorable conditions, assets, and environments 
that allow them to successfully engage in and benefit from the opportunities that arise from 
innovation.  
 
For the empirical part of the study, the paper aims to explore the concepts of innovation and 
internationalization within Puerto Rico’s pharmaceutical industry, and explain how 
internationalization is perceived to drive innovation. Puerto Rico has a very strong 
pharmaceutical cluster. As reported by Healthcare and Life Sciences Review (2015), the 
country has an enormous industrial impact, as it comprises the fifth largest territory in the 
world for pharma manufacturing and has significantly increased its capabilities for research 
and development. As such, Puerto Rico’s total manufacturing sector is dominated by the 
pharmaceutical sector, with 61% of its total manufacturing being pharmaceuticals. In 2013, 
the industry generated $43,800 million in exports (71% of total exports), and as of 2015 it 
represents 26.5% of the Island’s gross domestic product. In that year, the industry also 
experienced market sales of $3.5 billion, representing a 10.5% growth compared to previous 
years (IMS Health 2015). Additionally, the pharmaceutical industry has made other 
significant contributions to the Puerto Rican economy, such as the generation of over 78,000 
jobs (18,000 direct and 60,000 indirect), the development of an assets base of $10 billion, 
and an industrial environment that has contributed to the creation of local businesses that 
today have extensive international participation. (Pharmaceutical Industry Association 
2015.)  
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From thorough investigation, the researcher of this study identified that the existing 
academic literature related to internationalization as a driver of innovation has not covered 
the pharmaceutical industry, and even less, this industry within Puerto Rico’s context. As 
such, this represents an extraordinary opportunity to make a significant contribution to 
current research by shedding new light on the subject. The MNC was chosen as the firm of 
focus of this study, given its important role within the international economy. As established 
by Wattanasupachoke (2002), the global economic expansion has been largely facilitated by 
their growth, which currently lead world trade and capital movement. The author adds that 
the extent of their power has reached the point in which many of them have turnovers 
exceeding the gross national product of some countries. Thus, as these corporations continue 
to grow, they continue to influence the landscape of the world economy. Additionally, 
Miozzo and Soete (2001) establish that MNCs present appropriate conditions for the 
development of innovation, which is of extreme relevance for this research, as innovation is 
one of the main concepts under study. Moreover, the pharmaceutical industry is global by 
nature (ABPI 2016), with a sector value of $750 billion (Euler Hermes Economic Research 
2016), thus presenting an inherent multinational inclination. Given that the empirical 
findings of this research focus on the phenomenon under study within a particular industrial 
and geographical context, these should not be generalized as applicable to every industry or 
company.  
 
 
1.4. Structure of the study 
 
 
The study is divided into nine chapters. Chapter 1 provides the background of the study, 
covering the scope of the research, the research questions and objectives, and the structure. 
Chapters 2 to 6 comprise the literature review of the research, and are aimed at achieving 
the theoretical objective of the study (TRO: Thoroughly explore the concepts of innovation 
and internationalization, taking a deeper look into the literature explaining the relationship 
between both concepts). As such, these chapters provide the overarching theoretical 
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foundation of the study’s research questions. Chapter 2 explains the concept of innovation, 
presenting the types of innovation and main innovation strategies present in literature. 
Chapter 3 explains the concept of internationalization, further discussing the motives for 
internationalization, the process of entering foreign markets, and the types of foreign entry 
modes. The reason for providing comprehensive backgrounds of innovation and 
internationalization is to understand the underlying theoretical basis of the thesis and provide 
an exhaustive foundation that allows for a deep understanding of the two main concept under 
study. Further, Chapter 4 presents the knowledge – based view and how this is related to the 
capacity to innovate. Presenting the theory related to the knowledge – based view becomes 
important within this study because, as will be discussed further, knowledge has become an 
essential asset for firms engaging in international operations, playing a crucial role in how 
internationalization drives innovation. Chapter 5 presents the most relevant 
internationalization models and theories, given the empirical findings of this study. 
Furthermore, Chapter 6 links the previous concepts of innovation and internationalization, 
discussing the existing academic literature regarding their relationship. In the aim of 
exploring and explaining how internationalization drives innovation, the paper goes on to 
provide a review of the theoretical evolution present in literature. Within the theoretical 
evolution, certain elements that are believed to play important roles in how 
internationalization influences innovation will be discussed, such as knowledge, internal and 
external networks, and the influence of centralized and decentralized organizational 
structures. Moreover, Chapter 7 will explain the methodological structure of the paper, 
addressing the research purpose, design and strategy, as well as the data collection method 
and their respective justifications. Further, Chapter 8 will present the empirical findings 
gathered through the observed data, analyzing the information with the aim of exploring and 
explaining how internationalization is perceived to drive innovation within Puerto Rico’s 
pharmaceutical industry. Finally, Chapter 9 concludes the research by presenting the main 
findings, managerial implications, limitations, and suggestions for further research.  
 
 
 
22 
 
2. INNOVATION  
 
In order to explore and understand how internationalization drives innovation, it first 
becomes important to thoroughly discuss the main concepts under study. As such, the 
following chapter presents a comprehensive theoretical review of innovation. As one of the 
central elements of the paper, its discussion will provide a stronger theoretical foundation 
that will facilitate the understanding and answers to the research questions. 
 
Innovation has become a relevant topic of research amongst scholars worldwide. It is 
currently regarded as a key ingredient for business success and considered one of the most 
important elements in business activity (Castaño et al. 2015). Most importantly, innovation 
is extensively acknowledged as being important to the ability of companies to compete both 
domestically and internationally (Ren et al. 2015). Hence, it becomes pertinent to study the 
concept more in depth.  
 
Considering that innovation has been widely studied in business literature, there are naturally 
diverse explanations of the concept. Kanter (1984: 20) provides a comprehensive definition 
that includes several important components. The author defines innovation as “the 
generation, acceptance, and implementation of new ideas, processes, products, or services. 
It can thus occur in any part of a corporation and it can involve creative as well as original 
invention. It involves the capacity to change and adapt.” This definition provides an 
exhaustive perspective of innovation, presenting the complete process, from its initial 
inception, to its compliance and final application. Additionally, the author presents an 
interesting statement regarding how innovation provides a degree of novelty that, 
consequently, brings change. This change, however, has a level of desirability and 
intentionality (West and Farr 1990). Another explanation of innovation is provided by the 
Oslo Manual (2005: 46), which defines it as “the implementation of a new or significantly 
improved product (good or service) or process, a new marketing method, or a new 
organizational method in business practices, workplace organization or external relations.” 
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Additionally, Baregheh et al.  (2009) define it as the “multistage process whereby 
organizations transform ideas into new/improved products/services or processes, in order to 
advance, compete and differentiate themselves successfully in their marketplace.” From the 
definitions aforementioned, it can be derived that, although diverse explanations of 
innovation exist, they all present several common denominators, namely novelty and 
uniqueness. As established by Buse et al. (2010), this novelty does not necessarily involve 
new knowledge per se, but can also concern the advancement of existing knowledge. As 
such, novelty and uniqueness in innovation can be acquired either in their entirety or through 
incremental and continuous improvements. As stated by the authors, innovation is the result 
of a dynamic process that involves the exchange of diverse internal and external factors. 
Kyläheiko et al. (2011) support this view and add that within international business, 
innovation is “related to the firm’s ability to utilize its existing knowledge base and to 
acquire knowledge from external sources by means of imitation, licensing, partnerships or 
acquisitions.” These perspectives emphasize the importance of both internal and external 
knowledge in the process of innovation, which becomes essential when studying how 
internationalization drives innovation, as will be discussed in subsequent sections.  
 
 
2.1. Types of innovation 
 
 
Innovation can take diverse forms. However, it has been classified into four main groups: 
product, process, paradigm, and position (Francis and Bessant 2005; Bessant and Tidd 
2007:13). Product innovation relates to changes and improvements in the goods or services 
that organizations offer; process innovation relates to new or improved methods in which 
these goods or services are produced and delivered; paradigm innovation, also referred to as 
“organizational innovation,” regards new organizational methods implemented by firms 
which frame what they do in terms of business practices, workplace organization, or external 
resources; and finally, position innovation, also referred to as “marketing innovation,” 
relates to the changes in the contexts in which the products or services are introduced, such 
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as  new or improved product designs, packaging, placements, distribution, promotion, and 
pricing (Baregheh et al. 2012; Dabić et al. 2012).  
 
From the discussion, innovation is broad (Filippetti et al. 2013) and may be implemented to 
different parts of business, depending on firms’ needs and objectives. In general, Filippetti 
et al. (2013) establish that innovation can be categorized into two major groups: 
technological or organizational innovation. They state that they are both dependent on 
certain factors, such as type of input, macro and micro environments, government policies, 
and the degree of internationalization of firms. However, they are interconnected and 
complementary and can have a significant impact on performance. While there are diverse 
classifications, research suggests that innovation types are interdependent, as the 
implementation and adoption of one type of innovation may require or lead to the 
implementation or adoption of another type (Wischnevsky et al. 2011). The Oslo Manual 
(2005:18) establishes that the minimum requirement for an innovation is that it, whether 
related to the product, process, organization, or marketing, must be new or significantly 
improved to the firm.  
 
 
2.2. Innovation strategies 
 
 
When selecting an innovation strategy, companies have to select the type(s) of innovation 
that will allow them to create and capture the most value, and identify what resources each 
type should receive (Pisano 2015). The author establishes that technological innovation has 
historically been an essential creator of economic value and a pivotal driver of competitive 
advantage. However, he argues that not all innovations are related to technology, and that 
business model innovation has become very relevant in recent years. In this sense, when 
thinking about economic opportunities, companies should decide how to go about the two 
dimensions: how much of their innovative efforts to include towards technological 
innovation and how much to invest in business model innovation. To address this issue, the 
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author developed an innovation matrix, known as “The Innovation Landscape,” which 
evaluates how a potential innovation integrates with a company’s existing technical 
capabilities and business model. (Pisano 2015.) Figure 1. presents the matrix and, following, 
the paper takes a deeper look at each category.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. The Innovation Landscape Matrix (Pisano 2015). 
 
As there are significant differences in the nature of the innovation implementation of firms 
(Orlikowski 1991), there has been considerable discussion concerning its categorization 
(Baregheh et al. 2012). According to Baregheh et al. (2012), the two main approaches 
discussed in research regard the classification of innovation in terms its nature and degree. 
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Based on this, research has mainly classified innovation as radical or incremental (Dewar 
and Dutton 1986; Orlikowski 1991; Bessant and Tidd 2007: 14). According to O’Sullivan 
(2008: 23) radical innovation, also referred to as “breakthrough” innovation, relates to 
making major changes in something existent. Pisano (2015) argues that the challenge with 
this category is essentially technological. Dewar and Dutton (1986) add that it is related to 
paradigmatic changes, representing significant differences from prevalent practice or 
knowledge. As such, this type of innovation changes the existing innovative paradigms 
within firms and industries. While implementing radical innovation can be highly beneficial 
for firms in terms of increased sales and profits, it is also highly resource – intensive and 
risky (O’Sullivan 2008: 23). The author establishes that this is especially true within the 
pharmaceutical industry, in which companies invest millions of dollars in developing new 
drugs and yet have no guarantee that they will ever pass regulatory and clinical trials and 
make it to the market. On the other hand, incremental innovation, also referred to as 
“sustaining” or “routine” innovation, also represents accumulative changes in products or 
processes, but through minor improvements or adjustments that fit with the company’s 
existing business model (Dewar and Dutton 1986; Pisano 2015). Many firms undertake 
innovation under this approach, implementing small, incremental innovations to their 
products, processes, and services (O’Sullivan 2008: 24). However, if firms successfully 
implement enough incremental innovations, these can sometimes lead to similar levels of 
growth as those achieved by radical innovations (Dewar and Dutton 1986). In fact, Pisano 
(2015) highlights the role of routine innovation by establishing that a vast majority of profits 
are achieved through it. The main drivers of incremental innovation include approaches to 
continuous improvement such as lean manufacturing, total quality management, and world 
– class manufacturing (O’Sullivan 2008: 24), as is often the case of the pharmaceutical 
industry. Disruptive innovation is an additional type of innovation that has also been widely 
studied (Reinhardt and Gurtner 2015). Also referred to as “transformational” innovation, it 
could be considered the most groundbreaking type of innovation from the three types 
previously discussed, as disruptive innovations often change the way markets behave and 
the subsequent innovations that are developed. In other words, they change the “rules of the 
game.” The theory of disruptive innovation goes back to the work of Abernathy and Clark 
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(1985), who relate such innovation to technical innovation by suggesting that disruptive 
innovations often destroyed the value of prevalent technical capabilities (Christensen and 
Bower 1996). However, the concept eventually broadened and now includes not only 
technologies but also products and business models that allow firms to deliver superior value 
to customers (Christensen 2006; Markides 2012; Pisano 2015). Lastly, architectural 
innovation is what Pisano (2015) refers to as a combination of technological and business 
model disruptions, stating that it is the most challenging innovation category to pursue. It is 
important to note, however, that while there are evident differences between the 
aforementioned innovations strategies, the author argues that there is not one preferred type. 
In fact, over time, different kinds of innovation can become complements, rather than 
substitutes. (Pisano 2015.) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
28 
 
3. INTERNATIONALIZATION 
 
 
After discussing the concept of innovation, this chapter presents a comprehensive review 
regarding internationalization, given that it is the other central element of the paper. Its 
explanation and discussion will also provide a stronger theoretical foundation that will 
facilitate the understanding and answers to the research questions. 
 
Internationalization has become a widely studied phenomenon over the last decades and, 
according to Zhang (2008), it has developed as the main feature of the current world 
economy. It is not a new concept, but has recently become an important business strategy 
(Sdiri and Ayadi 2014), because as many companies develop and grow, their need to expand 
to foreign markets has become essential. Management literature has established that 
internationalization has become a standard requirement for successful business (Kumar et 
al. 2013), as it represents a significant opportunity for growth and value creation in 
organizations (Buckley and Casson 1976; Lu and Beamish 2001; Kyläheiko et al. 2011). In 
support, Buckley and Ghauri (1993) establish that the growth of the firm provides a 
foundation to internationalization and, to some degree, the concepts of internationalization 
and growth are intertwined. Internationalization has also introduced new and complex 
challenges, and firms engaging in foreign markets are constantly faced with issues regarding 
international decision – making and management, the development of international 
activities, and factors favoring or disfavoring internationalization (Ruzzier et al. 2006).  
 
As defined by Hitt et al. (1994), internationalization relates to “expanding (activities) across 
country borders into geographical locations that are new to the firms.” Another definition 
provided by Ruzzier et al. (2006) presents internationalization as “the geographical 
expansion of economic activities over a national country’s border,” adding that it is also 
considered “a changing state.” As will be discussed further, there are diverse reasons for 
firms to internationalize.  
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3.1. Motives for internationalization  
 
 
The increasingly global business environment has led to significantly higher international 
integration and interdependence (Wattanasupachoke 2002). Firms are now presented with 
unique opportunities that allow them to expand their participation and geographical reach. 
This process has been facilitated by important advances in technology, state of the art 
infrastructure (international communication and transportation), falling trade barriers, 
deregulation and homogenization of global markets, and saturation of local demand (Yip 
1989; Oviatt and McDougall 1994; Ripollés and Blesa 2012; Kumar et al. 2013). These 
advances have simplified and shortened the process of firm internationalization (Oviatt and 
McDougall 1994). They have also created favorable institutional and economic conditions 
that represent extraordinary growth opportunities for firms, making internationalization a 
vital strategy to expand their operations rapidly and exploit new business opportunities at a 
global scale (Ren et al. 2015). This progress has greatly increased global competition, 
making internationalization a necessity for growth, and not merely an option. As stated by 
Wattanasupachoke (2002), internationalization “has become one of the key strategic 
decisions for firms to maximize or at least sustain profits to survive in the world of 
uncertainty and complexity.” 
 
Firms decide to internationalize their economic activities for an array of reasons, and while 
their motivations are often mixed and numerous, internationalization is often associated with 
firms’ pursue of market gain, profitability, and growth. While some firms go abroad to 
expand their products by exporting or establishing subsidiaries, many firms go abroad to 
have access to know – how and technologies in order to stay competitive. These reasons 
vary depending on their needs and objectives, as well as on the opportunities of the foreign 
market (Albaum et al. 1998). As such, firms have diverse motivations and, thus, adopt 
different internationalization approaches.  
 
30 
 
Yip (1989) establishes that there are four main drivers that impulse firm internationalization. 
These are: (1) market drivers, (2) cost drivers, (3) government drivers and (4) competitive 
drivers. Market drivers are based on homogeneous customer needs, global customers, global 
channels, and transferable marketing, all of which allow for uniform international marketing 
strategies. Cost drivers refer to economies of scale and scope, learning and experience, 
sourcing efficiencies, favorable logistics, differences in country costs and skills, and reduced 
global development costs. Government drivers, on the other hand, refer to favorable trade 
barriers, compatible technical standards, and common marketing regulations. Finally, 
competitive drivers refer to the increasing interdependence of countries as globalized 
competitors. (Yip 1989.) Wattanasupachoke (2002) establishes that the internationalization 
process of firms may be driven by external or internal triggers.  However, as the author 
explains, internationalization often results from a combination of both. The internal triggers 
influencing internationalization relate to the changes that occur within firms, representing 
their constitutional strengths and weaknesses. These include the vision of executives and the 
risk aversion of the decision makers. The external triggers of internationalization, on the 
other hand, are the factors outside the control of firms, representing their opportunities and 
threats. (Wattanasupachoke 2002.) These internal and external triggers are determinant in 
the choice of entry modes made by firms (Ravelomanana et al. 2015). 
 
 
3.2. Entering foreign markets 
 
 
Root (1994: 324) establishes that choosing an entry strategy for international markets 
requires a comprehensive plan in which the firm sets forth the objectives, goals, resources, 
and policies that will guide its international business operations over a future period. As 
such, determining the appropriate entry mode is a complex process that requires much 
analysis and in – depth considerations of a variety of factors. Luo (2002: 181) establishes 
that entry strategies concern where (location), when (timing), and how (entry mode) MNCs 
should enter and invest in a foreign country during their international expansion. According 
31 
 
to the author, these strategies are important because they influence the internationalization 
process, mainly the “investment environment, operation treatment, resource commitment, 
and evolutionary path.”  
 
The selection of the location (where) regards the country and specific region in which a 
company’s foreign project is to be located. This process is influenced by certain 
considerations, such as: cost and tax factors, demand factors, strategic factors, regulatory 
and economic factors, and sociopolitical factors. Cost and tax factors relate to transportation 
and construction costs, wage rates, availability and costs of land, costs of raw materials and 
resources, financing costs, tax rates, investment incentives, and profit repatriation. On the 
other hand, the demand factors regard market size and growth, potential customers, and local 
competition. The strategic factors relate to the investment of the infrastructure, the strength 
of the existing manufacturing activities, the industrial connections, the workforce 
productivity, and the inbound and outbound logistics. Furthermore, the regulatory and 
economic factors consist of industrial policies, FDI policies, and existence of special 
economic zones. Finally, the sociopolitical factors involve political stability, cultural 
barriers, local business practices, government efficiency and corruption, attitude towards 
foreign business, market characteristics, and pollution control. (Luo 2002: 181- 190). On the 
other hand, the selection of the timing (when) is related to the period frame in which the 
company enters the foreign market(s). This is very important because being an early or late 
mover determines the risks, environments, and opportunities these firms may encounter. 
Being a pioneer in the market has several advantages, particularly related to acquiring market 
power. For example, early movers have better chances of investing in facilities, distribution 
networks, product positioning, patentable technology, natural resources, and human and 
organizational know-how. Additionally, they are presented with unique opportunities to 
form exclusive and deeper relationships with their markets, which could potentially lead to 
customer loyalty. Moreover, market pioneers gain from many preemptive opportunities. For 
example, early movers have the right to acquire marketing, promotion, and distribution 
channels, while increasing their product image, reputation, and brand recognition. 
Additionally, early movers are presented with more strategic options in selecting industries, 
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locations, and market orientations. They are also given priority access to resources, 
materials, distribution channels, promotional arrangements, and infrastructure. However, 
being an early mover also comes with its downside. For example, they confront greater 
degrees of environmental uncertainty and operational risks. This is not the case for late 
movers, who enter markets when they are already stable, regulatory conditions are more 
favorable, and infrastructure is already available. Market pioneer disadvantages also relate 
to the high costs they have to pay in order to settle and learn in the foreign markets. (Luo 
2002: 192- 195.) However, even though location and timing are critical to successful market 
entry, in today’s increasingly globalized market, entry modes (how) have gained particular 
attention and importance (Baena and Cerviño 2015).  
 
While firms are presented with a variety of options for entering foreign markets, they need 
to identify and thoroughly analyze the strengths and weaknesses of each entry mode. The 
choice of such modes is critical, as they determine the “degree of foreign involvement in 
host economies, level of foreign control of local operations, and their level of impact in the 
local economy” (Contractor and Kundu 1998). Therefore, it is evident that the selection of 
foreign entry modes is determinant on the level of ease or difficulty of market entry, as well 
as the survival of firms in such markets.  
 
 
3.3. Types of foreign market entry modes 
 
 
A foreign market entry mode is “an institutional arrangement that makes possible the entry 
of a company’s products, technology, human skills, management or other resources into a 
foreign country” (Root 1987: 5). In other words, they are corporate agreements for 
coordinating and conducting international business transactions (De Villa et al. 2015). Their 
selection is not easy (Brassington and Pettitt 2000: 1079), as there are many relevant factors 
that firms need to take into consideration according to their needs and objectives in the host 
markets (Ravelomanana et al. 2015). As established by the authors, some of the criteria firms 
33 
 
need to consider are: level of investment (indirect or direct), production of goods or services 
(home or abroad), relationship between exporter and buyer (direct or indirect), and width of 
transaction (if it involves exporting goods and services, knowledge and expertise or 
investment). Research shows that entry modes also influence the flow of information 
between the firm and the foreign market (Johanson and Wiedersheim – Paul 1975; Johanson 
and Vahlne 1977). As such, they facilitate or impede firms’ access to the foreign market 
knowledge resources that they need in order to adapt and overcome differences in language, 
business practices, culture, political systems, industrial development, or geographic distance 
(Johanson and Vahlne 1977; Dow 2000; Mogos – Descotes and Walliser 2010).  
 
The entry approaches adopted by firms may vary depending on different factors, such as 
firm type, size, industry, international objectives, and available resources. While some firms 
may prefer to internationalize their production, other may decide to internationalize their 
whole business (Kafouros et al. 2008). Malhotra and Hinings (2010) establish that different 
businesses have different needs, and thus require distinct approaches to internationalization. 
As stated by the authors, “each organization type responds differently to critical elements of 
the internationalization process, namely, the focus of entry, the degree of presence, and 
physical presence requirements in the foreign market.” The responses to these factors 
influence what modal forms are appropriate.  
 
As previously mentioned, the ways in which firms internationalize operations and economic 
activities can take diverse forms. Wattanasupachoke (2002) states that the level of 
involvement of firms in international business can be categorized in different types of foreign 
entry modes, ranging from import and export entry modes, contractual entry modes, and 
investment entry modes. While imports and exports are the conventional forms of 
international activities of firms, firms can choose from a variety of other modes: licensing, 
franchising, contracting, sales subsidiaries, manufacturing subsidiaries, wholly owned 
subsidiaries, joint ventures, acquisitions, strategic alliances, management contracts, turnkey 
contracts, subcontracting or associations, and consortiums, etc. (Brassington and Pettitt 
2000; Malhotra 2003; Wild et al. 2003; Armstrong and Kotler 2005: 581). International 
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licensing and franchising are examples of contractual entry modes, while investment entry 
modes encompass joint ventures, consisting of contractual operations, equity joint ventures 
and strategic alliances, and sole ventures or wholly owned subsidiaries (Wattanasupachoke 
2002).  
 
Interestingly, knowledge has become a relevant subject within the selection of market entry 
modes, as MNCs are increasingly dealing with the transfer of knowledge assets throughout 
their international divisions (Malhotra 2003). Consequently, a main concern has been the 
protection of knowledge from threats of opportunism. According to Malhotra (2003), these 
threats are undermined with the development of different types of knowledge within the 
firm, making them sources of competitive advantage. The author establishes that knowledge 
held at the individual, team, and organizational levels combine to generate a source of 
advantage for the firm. These types of diversified knowledge include: individually – held or 
team – held knowledge, such as technical and/or experiential knowledge; knowledge of 
personal relationships and connections; and knowledge of the host country/ies, also known 
as “market knowledge.” (Maholtra 2003.) Additionally, some entry modes are believed to 
foster knowledge within the MNC context. For example, according to Grant and Baden – 
Fuller (2004), strategic alliances increase knowledge specialization and cause broadening of 
the firm’s knowledge base. The authors establish that strategic alliances embrace a diversity 
of collaborative forms. These cover: supplier-buyer partnerships, outsourcing agreements, 
technical collaboration, joint research projects, shared new product development, shared 
manufacturing arrangements, common distribution agreements, cross-selling arrangements, 
and franchising.  
 
 
 
 
 
 
 
35 
 
4. KNOWLEDGE – BASED VIEW OF THE FIRM 
 
 
While much attention has been placed on the traditional resource – based view of the firm, 
recent studies have developed another approach to this theory: the knowledge – based view 
of the firm (KBV). As one of the main motivators of global innovation, access to knowledge 
has become particularly relevant (Buse et al. 2010). It has been argued that to perform well, 
firms cannot rely solely on conventional resources and capabilities, but also require the “tacit 
collective knowledge embedded in the firm’s routines to integrate, coordinate, and mobilize 
those resources and capabilities successfully” (Grant 1996). Other authors confirm that 
firms’ unique knowledge, as well as the ability to create and transfer it across their divisions, 
are considered a strategic asset that may be positively associated with higher levels of 
performance, as they are difficult to trade and imitate, and are scarce, appropriable, and 
specialized (Nonaka and Takeuchi 1995; Bierly and Chakrabarti 1996; Spender 1996; Teece 
1998). Business literature also affirms that knowledge – based resources and the creation of 
knowledge through learning are fundamental mechanisms that lead towards “competitive 
advantages and business success” (Mogos – Descotes and Walliser 2010). In the same way, 
companies who seek to actively identify, develop, and implement their unique knowledge 
resources are presented with an exclusive set of assets that can increase their innovative 
performance.  
 
Given these findings, it can be drawn that knowledge plays an essential role in the 
development of the innovative competitive advantages of firms, particularly those with 
international participation, as a rise in global presence leads to increased external knowledge 
sources. As established by Chiva et al. (2013), “organizational learning, innovation and 
internationalization are key ingredients for the knowledge-based economy in the age of 
globalization.” Cohen and Levinthal (1990) argue that external sources of knowledge are 
critical to the innovation process.  
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Networks have had an increasingly important role in the knowledge development of firms. 
In this way, collaborative relationships are now considered an extremely important form of 
organization of innovative activities. This is particularly true within the pharmaceutical 
industry, where the role of scientific knowledge in research is emphasized and the nature of 
the learning processes foster the development of networks. (Orsenigo et al. 1998.) 
 
It has been widely proposed that innovation has a positive impact on corporate performance. 
In this way, increasing investments in innovation essentially allows firms to develop and 
license new technologies, adopt more efficient production techniques, introduce new 
products and processes, and consequently become more competitive and increase their 
economic performance (Kafouros et al. 2008). However, several scholars have argued that 
not all firms benefit from their innovative efforts (Link 1981), presenting several limitations 
to the knowledge – based view regarding innovation. Shearmur et al. (2015) establish that 
even though firms can open themselves to external markets, they may not be able to 
appropriate all the information and knowledge to which they have access, as they may not 
always recognize their potential value or have the capacity to incorporate them to their 
existing knowledge base. As the author explains, this is explained by the tacit characteristics 
of knowledge. Research has established the difficulties of transferring tacit and complex 
knowledge within organizations (Zander and Kogut 1995; Szulanksi 1996). 
 
A predominant theoretical explanation as to why some firms are more likely to benefit from 
external knowledge than others involves the concept of absorptive capacity, introduced by 
Cohen and Levinthal (1990). The authors define absorptive capacity as “as the ability of a 
firm to recognize the value of new, external information, assimilate it, and apply it to 
commercial ends”, identifying it as “critical to its innovative capabilities.” They add that to 
the degree that absorptive capacity is important to firms, investment in research and 
development, as in the case of the pharmaceutical industry, for example, can lead to 
increased absorptive capacity and, thus, to higher performance. According to Shearmur et 
al. (2015), this becomes especially important because such absorptive capacity “contributes 
directly to innovation by allowing for the identification and translation of external 
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knowledge inflows into tangible benefits for the firm.” As such, developing a strong 
absorptive capacity is essential. Additionally, O’Cass and Sok (2012) define innovation 
capabilities as the “bundle of interrelated processes a firm has in place to facilitate and 
implement successful development, evolution, and execution of product innovation.” Sok et 
al. (2013) establish that having superior innovation capabilities is key for increased firm 
performance. Several studies have determined that this capacity to innovate allows firms to 
stay competitive, as it assists them in developing superior products to meet their customers’ 
changing needs and demands (Verhees and Meulenberg 2004; Li and Mitchell 2009; 
Rosenbusch et al. 2011). This is pivotal in order to succeed in the marketplace (Sok et al. 
2013), which becomes crucial for firms with international participation. 
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5. INTERNATIONALIZATION PROCESS THEORIES AND MODELS 
 
 
As this study aims study how internationalization drives innovation, it becomes important 
to present diverse internationalization models adopted by firms, in order to further analyze 
throughout the research how they influence innovation. The increasing understanding of the 
ever – changing nature of MNCs has led to two broad classifications that can help determine 
the focus of their internationalization approach. These are economic theories and behavioral 
theories. While traditional research regarding MNC internationalization have focused on 
economic theories, this study explores various internationalization models that stem from 
the behavioral theories, which represent the general internationalization approach within the 
sample of this study.  
 
Within the MNC context, there are diverse approaches to internationalization. As will be 
further discussed, some consist of gradual, incremental steps towards international 
expansion, while others are based on collaborative relationships and networks. The 
appropriateness of the internationalization model(s) selected by MNCs depend on the 
industrial context to which they are applied (Andersson 2004). According to the author, the 
usefulness of these models depend on firms’ degree of internationalization and whether their 
industries are mature or growing. Acknowledging this, not all theories apply to every MNC 
case. However, they can complement each other. The chapter presents several important 
internationalization models adopted by firms: the Stages Models (Uppsala 
Internationalization Model and Innovation – related Models) and the Network Theory.  
 
 
5.1. Stages Models 
 
 
Murray and Ron (2010) establish that innovation has been linked to internationalization 
through the stages models approach, where internationalization is seen as a cautious and 
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progressive process. The stages approach to internationalization suggests that companies 
initially serve their home markets and then gradually increase their international 
involvement, most often as a result of incremental learning (Baronchelli and Cassia 2008). 
The stages models discussed in the paper are: the Uppsala Internationalization Model and 
Innovation – related Models. These are discussed because they represent the overall 
internationalization behavior of the studied sample.  
 
5.1.1. The Uppsala Internationalization Model  
 
The Uppsala Internationalization Model (U – Model) (Johanson and Wiedersheim – Paul 
1975) is arguably one of the most studied approaches to internationalization and particularly 
relevant for this study as it represents the internationalization approach adopted by several 
of the interviewed companies. The U – Model views the internationalization process of firms 
as the product of a series of incremental decisions, where companies initially develop in their 
domestic markets, and where internationalization is the consequence of a series of gradual, 
cumulative decisions. In this model, internationalization is seen as a process companies 
develop as changes and advances occur within them and their environment (new problems 
and opportunities). In other words, firms move on their internationalization path following 
logical steps that are based on their gradual gain and use of information acquired through 
foreign markets and operations. The outcome of one decision is the input of another, making 
decisions interdependent of each other.  
 
The U – Model arose from the understanding that many firms internationalize their 
operations while still relatively small, gradually developing their activities abroad, contrary 
to substantial initial foreign investments. As established by Carneiro et al. (2008), the Model 
states that firms will first seek to internationalize to psychically close countries (markets 
with short psychic distance) and gradually move to more distant markets. This is due to 
difficulties of understanding foreign environments, primarily related to differences in 
language, education, culture, business practices, political systems, and level of industrial 
development (Johanson and Wiedersheim – Paul 1975).  
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The U – Model distinguishes four stages of internationalization, each representing a higher 
degree of international involvement. These are: no regular export activities, exports done 
through independent representatives (agents), sales subsidiaries, and production and 
manufacturing (Johanson and Wiedersheim – Paul 1975). The authors describe these stages 
as an establishment chain, and they represent the expansion patterns. Further, as established 
by Forsgren (2002), there are three basic assumptions encompassing the U – Model. The 
first assumption states that the lack of knowledge about foreign markets is considered a major 
obstacle to international expansion. However, such knowledge can be acquired. The author 
states that acquiring knowledge highly depends on being active in the new environment 
rather than on just collecting and analyzing information. By being active within the market, 
firms not only acquire information about that market, but also become so closely connected 
to the market that it becomes “difficult to use its resources for other purposes.” As Johanson 
and Vahlne (1990) state, the main source of knowledge is the firm’s own operations. From 
this first assumption, it is drawn that an active participation of firms in their foreign markets 
is their main source of learning.  
 
The second assumption is that market uncertainty is one of the principal reasons why firms 
invest in foreign markets incrementally and not substantially in the beginning. The more 
firms know about their markets, the lower the perceived market risk will be, leading to higher 
levels of foreign investment in that market throughout time (Forsgren 2002). This second 
assumption regards the decrease of risk and, thus, increase of investment, once sufficient 
market information is gathered. The third and final assumption states that knowledge highly 
depends on individuals and is, thus, difficult to transfer to other individuals and contexts. 
This last assumption relates to the complication of transmitting experience, mainly because 
experience “produces a change [...] in individuals and cannot be separated from them” 
(Johanson and Vahlne 1977). This presents a challenge, as the problems and opportunities 
innate to a specific market will most likely be identified and solved by the people who are 
working in such market (Forsgren 2002). However, as stated by Johanson and Vahlne 
(1990), experience can work as a driving force in the internationalization process of firms.  
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Under the U – Model approach, there is a distinction between state and change aspects of 
internationalization. State aspects are the commitment to the foreign market (market 
commitment) and the knowledge about the foreign markets and operations (market 
knowledge). Market commitment can be analyzed through amount of resources that have 
been committed (amount of investment in the market) and the degree of commitment 
(difficulty of identifying an alternative use for the resources and transferring them to such 
alternative use). Market knowledge within the U – Model, on the other hand, gains relevant 
attention. As established by Andersen (1993), internationalization requires both general and 
market – specific knowledge. According to Johanson and Vahlne (1977), general knowledge 
relates to marketing methods and common characteristics of certain types of customers, 
regardless of their geographical location. As such, this kind of knowledge can often be 
transferred between countries. However, market – specific knowledge regards methods that 
vary according to markets. As such, firms need to adapt their approaches to the diverse 
geographical contexts. This market – specific knowledge is gained mainly through 
experience, though there are also other possibilities to develop it. Additionally, the U – 
Model establishes a difference between objective and the experiential knowledge. While the 
objective knowledge can be taught by firms, the experiential knowledge, as previously 
explained, can be only acquired through personal experience. This latter type of knowledge 
gains particular importance as it is believed that experiential knowledge provides managers 
and employees with the pertinent background to perceive and formulate real opportunities, 
while objective knowledge regards mainly theoretical opportunities. Thus, experiential 
knowledge plays a key role in the internationalization of firms. Furthermore, the change 
aspects of the U – Model relate to the decisions to commit resources (commitment decisions) 
and the performance of the current business activities (current activities). Figure 2. 
summarizes the basic mechanisms to internationalization according to the U – Model. 
(Johanson and Vahlne 1977). 
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Figure 2. Internationalization through the Uppsala Internationalization Model (Johanson 
and Vahlne 1977). 
 
 
The Model, however, presents some limitations, as it does not explain what produces the 
first internationalization step. It also does not explain the behavior of already established 
MNCs that have extensive international experience. In addition, the U – Model does not 
explain why some firms do not follow the logical sequence suggested by the model and why 
some firms are born – globals. Born global companies are those that conduct international 
business at or near their founding (Knight and Liesch 2016). In other words, they are early 
adopters of internationalization. As Oviatt and McDougall (1994) put it, they have an 
“international vision [...] from inception.”  
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Recently, the U – Model was updated and several additional elements were included. 
According to Johanson and Vahlne (2009), environmental business changes and the 
development of the network theory, which will be discussed further in the chapter, called for 
changes in the model. Trust became an important factor in successful learning and 
development, as well as in relationships, commitments, and decisions. The updated U – 
Model is based on the assumptions that existing business relationships have a considerable 
impact on the particular market a firm will decide to enter and on which specific mode to 
use. In addition, internationalization is now seen as being more dependent on developing 
opportunities than on overcoming uncertainties, as the recognition of opportunities was 
added to the knowledge concept.  
 
5.1.2. Innovation – related Internationalization Models  
 
The internationalization process of firms can also be studied from an innovation – related 
perspective, for which there are diverse models. These innovation – related 
internationalization models (I – Models) show the stages of the internationalization adoption 
process. In I – Models, each stage of internationalization is seen as an innovation for the firm 
(Andersen 1993; Gankema et al. 2000). Table 1. presents Andersen’s (1993) review of the 
most important I – models, summarizing their diverse stages to internationalization.  
 
 
Table 1. A review of innovation – related internationalization models (Andersen 1993). 
 
 
Bilkey and Tesar 
(1977) 
Cavusgil  
(1980) 
Czinkota  
(1982) 
Reid  
(1981) 
Stage 1  
Management is 
not interested 
in exporting  
 
 Stage 1  
Domestic 
marketing: The 
firm sells only to 
the home market  
Stage 1  
The 
completely 
uninterested 
firm  
 Stage 1  
Export awareness: 
Problem of 
opportunity 
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Stage 2  
Management is 
willing to fill 
unsolicited 
orders, but 
makes no  
effort to 
explore the 
feasibility of 
active 
exporting  
 
 
Stage 3  
Management 
actively 
explores the 
feasibility of 
active 
exporting  
 
 
Stage 4  
The firm 
exports on an 
experimental 
basis to some 
psychologically  
close country  
 
 
Stage 5  
The firm is an 
experienced 
exporter  
 
 
Stage 6  
Management 
explores the 
feasibility of 
exporting to other 
more  
psychologically 
distant countries  
 
 
Stage 2  
Pre-export stage: 
The firm searches 
for information and 
evaluates  
the feasibility of 
undertaking 
exporting  
 
Stage 3  
Experimental 
involvement: The 
firm starts 
exporting on a 
limited  
basis to some 
psychologically 
close country  
 
Stage 4  
Active 
involvement: 
Exporting to more 
new countries--
direct  
exporting--increase 
in sales volume  
 
Stage 5  
Committed 
involvement: 
Management 
constantly makes 
choices in  
allocating limited 
resources between 
domestic and 
foreign markets  
 
 
Stage 2  
The partially 
interested 
firm  
 
 
Stage 3  
The exploring 
firm  
 
 
Stage 4  
The 
experimental 
firm  
 
 
Stage 5  
The 
experienced 
small exporter  
 
 
Stage 6  
The experienced 
large exporter  
 
recognition, 
arousal of  
need  
 
Stage 2  
Export intention: 
Motivation, 
attitude, beliefs, 
and expectancy  
about export  
 
Stage 3  
Export trial: 
Personal 
experience from 
limited exporting  
 
Stage 4  
Export evaluation: 
Results from 
engaging in 
exporting  
 
Stage 5  
Export acceptance: 
Adoption of 
exporting/rejection 
of exporting  
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The I – models presented are argued to be very similar, sharing characteristics in terms of 
their sequential stages, although the number of stages differ (Andersen 1993). In the models 
developed by Bilkey and Tesar (1977) and Czinkota (1982), firms present no initial interest 
in foreign participation. However, this attitude towards internationalization gradually 
changes as they get involved in operations overseas, particularly through exporting. This is 
believed to be due to “push” factors or external changes that initiate the export decisions 
(Andersen 1993). On the other hand, Cavusgil (1980) and Reid (1981) developed models in 
which firms are more interested in international participation form earlier stages. This is 
particularly evident in the model developed by (Reid 1981), which presents an interest in 
foreign operations from the first stage, with a distinct export intention and motivation. As 
such, “pull” factors or internal changes are believed to be what drive firms to the next 
internationalization stages (Andersen 1993).  
 
The U – model and I – models discussed are often used to analyze large firms with the aim 
of explaining their development of internationalization and international activities (Ruzzier 
et al. 2006). It is important to note that their gradual behaviors are explained by two main 
reasons: lack of knowledge of the firm, particularly experiential knowledge; and uncertainty 
regarding the decision to internationalize (Andersen 1993).  
 
 
5.2. Network Theory 
 
 
As discussed previously, networks became an important element in the updated version of 
the U – Model (Johanson and Vahlne 2009). The theory was chosen in this study because 
throughout the empirical research, it became evident that networks in foreign markets play 
important roles in the internationalization of firms within the studies industry, given its 
global nature and interconnectedness. The network theory views industrial markets as 
networks of relationships between firms. Madsen and Servais (1997) establish that in the 
process of internationalization, the first step a firm must follow is understanding the market 
46 
 
where it operates, its environmental conditions, and the firm’s relationships. It is through 
these relationships that firms gain access to external resources that allow them to establish 
themselves successfully in foreign markets. Current literature on innovative firms has 
focused on the important correlation between the management style, the innovation activity, 
and the network relationships of the firm (Lipparini and Sobrero 1994).  
 
Nowadays, it can be argued that the degree of internationalization of firms highly depends 
on the number of networks they have and the strengths of such relationships. Johanson and 
Mattsson (1988) establish that as firms increase their international involvement, the number 
and strength of the relationships established within their networks consequently increase, 
helping all the more their international expansion. According to the authors, networks are 
stable and also changing, and the exchanges take place among existing relations that evolve 
with the transactions carried out. Studies have shown that there are different types of network 
relationships within innovative firms and that, in order to succeed, firms must expand them 
(Partanen et al. 2011). These network connections cover a wide range of areas within 
organizations, from technology – oriented relationships, to relationships with customers, 
suppliers, competitors, government, universities, and other research institutions (Johanson 
and Mattsson 1988; Powell et al. 1996; Maurer and Ebers 2006). Building networks and 
relationships among customers and suppliers becomes particularly important in global 
business settings, because mutually built and supported relationships allow for better results 
in the internationalization process. Business transactions with important customers generally 
take place within well – established, long – lasting relationships, and they require trust, 
commitment, and knowledge – sharing. Additionally, relationships with customers and other 
firms in the foreign markets provide unique market information (Rickne 2006) that help 
reduce liability of foreignness. These relationships with customers and firms become 
important within the context of this study’s empirical research, as will be further discussed.  
 
In the network theory, internationalization goes through different processes. First, there is 
an international extension, in which positions are established in relation to counterparts in 
nets new to the firm. Thus, in this initial stage, investments are made in the new networks. 
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Subsequently comes the penetration, in which the positions are developed and resource 
commitments increase in nets where the firm already has positions. Finally, international 
integration takes place, where there is an increasing coordination between positions in 
different national nets. (Johanson and Mattsson 1988.) The internationalization process 
through the network theory is summarized in Figure 3. 
 
 
 
Figure 3. Internationalization through the Network Theory (Johanson and Mattsson 1988).  
 
Having connections with networks within foreign markets aids the process of international 
expansion and fosters survival overseas. Consequently, through an exchange of these 
elements, the firm gains market penetration. After such process, firms can advance towards 
international integration by leveraging on the existing network and getting involved with 
other firms in their diverse markets. Through their position in the network, firms can use 
their relationships to gain access to markets and resources (Johanson and Mattsson 1988). 
 
As established by Orsenigo et al. (1999), “it is now widely recognized that collaborative 
relationships are an important form of organization of innovative activities, especially in 
high technology industries”, such as the pharmaceutical sector. Arora and Gambardella 
(1994) establish that network collaborations represent a new form of development of 
innovative activities, which are emerging due to the “nature” and “properties” of the learning 
processes within pharmaceutical research.  The increasingly codified and abstract nature of 
International 
Expansion
Penetration
International 
Integration
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the knowledge bases on which innovations result (Arora and Gambardella 1994) have fueled 
the development and evolution of networks (Orsenigo et al. 1999).  
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6. INNOVATION THROUGH INTERNATIONALIZATION 
 
 
Internationalization and innovation are two comprehensive areas of research that have often 
been studied independently in business literature. In fact, the previous chapters aimed at 
studying both concepts separately, in order to provide in – depth theoretical foundations that 
allow for a better understanding of their relationship, as will be discussed in this chapter. 
Significant changes in the international economy have pointed to a relevant interconnection 
amongst them. The increasingly competitive global business environment has made both 
concepts essential to gaining sustainable competitive advantage, and thus, for growth 
(Prashantham 2005). In order to conclude the theoretical objective of this study (TRO: 
Thoroughly explore the concepts of innovation and internationalization, taking a deeper 
look into the literature explaining the relationship between both concepts), the chapter will 
study the connection between both concepts, leading to the explanation of how 
internationalization acts as a driver of innovation. 
 
 
6.1. Cumulative causation 
 
 
During the last several decades, there has been an increase in the interest and publication of 
ongoing research regarding the connection between innovation and internationalization 
(Frenz et al. 2005; Onetti et al. 2012). They are both considered important strategic choices 
that firms adopt (Singh and Gaur 2013), and are gaining increasing attention for their 
contributions to corporate growth. The relationship between the two is often complex, as 
there are theoretical arguments why causation could go both ways: innovation to 
internationalization and internationalization to innovation (Filippetti et al. 2013).  
 
Filippetti et al. (2013) establish that the association between the two phenomena under study 
is based on strong theoretical grounds, arguing that both are linked by a cumulative causation 
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mechanism. Following this logic, the authors state that highly innovative firms can better 
compete and thus become more internationalized. On the other hand, internationalized firms 
are exposed to a broader range of cultures and innovative environments that strengthen their 
innovation performance. Veglio and Zuchella (2015) add that “product, process and 
managerial innovations can support international growth,” while “the exposure to foreign 
markets enhances learning opportunities,” which lead to innovation. According to these 
views, which cover both sides of the relationship spectrum, innovation provides firms with 
unique capabilities that allow them to internationalize successfully. However, 
internationalization allows firms to engage in diversified contexts that, in the same way, 
enhance their innovation. This latter perspective is what this chapter will further explore and 
explain. 
 
 
6.2. The internationalization – innovation relationship  
 
 
Existing research regarding the influence of internationalization on innovation performance 
has found a positive relationship (Castellani and Zanfei 2006; Frenz and Ietto-Gillies 2005; 
2007, 2009; Kafouros et al. 2008). According to Filippetti et al. (2013), innovation is the 
result of diverse factors operating at the macro, meso and micro levels, and one element 
underlying these levels is internationalization. At a broader level, Altomonte et al. (2013) 
state that policy measures encouraging internationalization have resulted from the implicit 
understanding that internationalization is associated with productivity growth, and thus, with 
economic growth. According to the authors, innovation is the channel through which such 
growth takes effect.  
 
Internationalization has been argued to have a positive impact on the innovation of firms in 
several ways. Kafouros et al. (2008) establish that internationalization enhances a firm's 
capacity to improve performance through innovation, as the innovation – performance 
relationship of firms is to a certain degree influenced by their degree of internationalization. 
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As they state, “firms need some threshold of internationalization and to be able to access a 
broad range of markets in order to benefit sufficiently from their new products and 
processes.” As such, innovation in itself is not enough, and a degree of international 
participation increases firms’ capacity to innovate and reap the benefits of such innovations.  
 
Hitt et al. (1997) establish that the access to foreign markets encourages firms to invest more 
on innovation projects, leading to improvements in their innovation performance. As such, 
internationalization in a basic sense is believed to stimulate innovation. Moreover, 
internationalization essentially allows firms to not only extend their knowledge resources, 
but also to capture new ideas and knowledge from other markets, which also enhance their 
innovation performance and intensity. Kotabe (1990) adds that internationalization provides 
firms with further market opportunities that support their innovations. For example, firms 
can benefit significantly from the new ideas arising from their diverse markets. Additionally, 
internationalization allows them to gain in terms of increased inter-firm and inter-region 
relationships and networks, which arise from the establishment of alliances and cooperation 
agreements with diverse actors in the markets, such as suppliers, customers, universities, and 
research centers (Santos et al. 2004).  Internationalization also allows employees to benefit 
from experiential learning and skills – sharing (Hitt et al. 1997).  
 
Moreover, from a financial perspective, internationalization provides favorable contexts that 
allow firms to reap the economic benefits of innovation. In this economic sense, Sdiri and 
Ayadi (2014) establish that innovation is regarded as one of the firm’s characteristics that 
can optimize the return to innovation. As established by Kafouros et al. (2008), high 
technological performance developed through innovation does not necessarily lead to high 
economic performance, as innovations often require substantial investments, which, along 
with relatively short life cycles, limit their economic benefits from such investments. 
Furthermore, as established by Hitt et al. (1997), firms operating in a limited number of 
markets might not be able to successfully cover the costs associated with innovation. 
However, internationalization allows firms to take advantage and appropriate the benefits of 
innovation, consequently enjoying higher returns on such innovations. For example, firms 
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engaging in international markets can charge premium prices (Kotabe et al. 2002), spread 
the undergone costs by offering their products to a larger number of promising buyers 
(Kafouros et al 2008), and benefit from economies of scale (Hitt et al. 1997).  Figure 4. 
summarizes the ways through which internationalization drives innovation.  
 
 
 
 
Figure 4. Ways through which internationalization drives innovation.  
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6.3. Theoretical evolution of the relationship  
 
With the increasing understanding of the ever – changing nature of MNCs, literature 
regarding the relationship between internationalization and innovation has seen significant 
shifts in perspectives throughout the years. In order to understand how the views have 
changed, this section provides an overview of the theoretical models that have been 
developed and studied in academia. As will be seen, particular attention is given to the role 
of knowledge in the relationship between the two phenomena.  
 
Recent studies have emphasized that the innovative success of firms depends on their ability 
to effectively organize and integrate extensive scopes of internal and external sources of 
scientific and technological knowledge (Dahlander and Gann 2010; Sammarra and Biggiero 
2008). As such, significant weight has been placed on the KBV of the firm previously 
discussed, which establishes that knowledge from diverse sources contribute to the 
innovative performance of firms (Grant 1996). This knowledge process and, thus, 
innovation, is facilitated through internationalization, because as firms expand, they gain 
access to unique and exclusive sources of information that they can use to innovate in their 
processes, products, organizational methods, and positions, etc. As such, internationalization 
is argued to influence the knowledge sources, which leads to driving innovation.  
 
However, the role of knowledge in the process of internationalization as a driver of 
innovation has not always been considered by research. Earlier theories of the relationship 
between internationalization and innovation merely stressed the nationality of the investor 
and, as such, the type of country where the innovative product originated (Frenz et al. 2005). 
During the 1960’s and 1970’s, the prevalent theoretical model of innovation development 
and diffusion in the context of internationalization derived from the International Product 
Life Cycle (IPLC), developed by Vernon (1966). The view of innovation that developed 
from the IPLC model related and analyzed innovation in respect to the product rather than 
the process or the firm as a whole or the industry (Frenz and Ietto-Gillies 2005). In the same 
way, this product – centered innovation activity was also country and firm – centered. 
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Furthermore, the theory led to a hierarchical view of innovation potential and activities, 
which led to several points. It established a hierarchy of countries (the United States, Europe, 
and developed countries), where the home country played a key role in innovation because, 
according to the theory, its innate environment helps the firm to build its competitive 
advantages in innovation. This innovation potential from the home country was linked to 
various elements, including macroeconomic and technological conditions, under the view 
that favorable income per capita, a large market, tastes of sophisticated consumers, and labor 
skills (engineering, production and marketing) create ideal conditions for the introduction of 
new products. The theory also established a hierarchy of firms (innovative and non-
innovative); a hierarchy of products (innovative and imitative), and a hierarchy of potential 
and actual innovation centers within the firm. Additionally, the IPLC theory was very limited 
in terms of decentralization of innovative activities. Particularly relevant is that there was 
limited interaction between subsidiaries, between these and their headquarters, and between 
subsidiaries and the local cultural and innovation environments of the host countries. (Frenz 
and Ietto-Gillies 2005; Frenz et al. 2005.) From the this paper’s standing point, the IPLC 
model fails to take into account other sources that support the innovative success of firms 
through internationalization.  
 
This perspective of innovation changed in the 1980s and 1990s, during which the general 
view shifted as a result of multiple developments in technology (Cantwell 1989; Frenz et al. 
2005). The new information and communication technologies facilitated the transmission of 
knowledge, the increase in foreign direct investment in services, and the growth in inter – 
firm collaborative agreements (Hagedoorn 1996; Narula 2000). According to Frenz and Ietto 
– Gillies (2005), these significant developments changed conditions in the micro and macro 
economy, which led to new outlooks on innovation. In the same way, the advancements 
allowed for further economic opportunities that transcended geographical borders. Firms 
were now seen as evolutionary institutions that had strong and influential interactions with 
their economic environments, both in national and international levels. During this 
evolutionary process, internationalization became key because it supported the interactions 
with these external environments that were facilitated through technological developments. 
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The evolutionary theory of the firm (Nelson and Winter 1982), has led to new advances in 
which the behavior and activities of international firms are linked to innovation development 
and diffusion. The “evolutionary aspect of the firm” was attributed in terms of the way these 
international firms organize their businesses and in their development of their competitive 
strategies, amongst which strategies on innovation play significant roles (Frenz and Ietto – 
Gillies 2005). 
 
Regarding this change in the perspective of innovation, Cantwell (1989), following a strong 
assessment of the IPLC model in a detailed study of the innovative behavior and outcomes 
of MNCs from six industrialized countries, developed his own theory. His approach to 
innovation was derived from the assumption that innovation and technological accumulation 
are used strategically by managers to enhance firms’ competitive advantages. In his 
approach, he took into account the relevant role of internationalization in the development 
of these competitive advantages. According to Frenz and Ietto – Gillies (2005), the main 
points of his theory lay in the following: ownership advantages in innovation can be created; 
innovation is transmitted internally to the firm from country to country; and there is a high 
degree of interaction between the firm and its external environment. In addition, the theory 
leads to the view of internal location advantages, which establishes that innovative activities 
within companies generate spillover effects and, thus, have external benefits on the local 
environment (Tushman and Anderson 1986; Cantwell 1989). Furthermore, and particularly 
pertinent for this study, his approach to innovation established that the subsidiary of an 
MNC, from its learning of its local environment, increases the scope for further innovation 
within the company as a whole. Thus, Cantwell’s (1989) theory introduced the 
understanding that through high degrees of interactions with their diverse geographical 
contexts, firms are able to further develop their innovative performances. As such, it can be 
argued, that a KBV of the firm was adopted, as it was now understood that as companies 
interact and learn from their environments through international expansion, they develop 
knowledge that can be used to innovate within them.  
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6.4. Innovation as a distributed process 
 
 
Innovation was originally perceived as a linear process, where firms relied almost entirely 
on knowledge created internally, and thus was characterized by a relatively low need for 
knowledge integration from external sources (Shearmur et al. 2015). This view has 
dramatically changed, as more recent understanding of innovation portrays it as an open and 
distributed process, recognizing the systemic and social dimensions of innovation and, 
especially, the importance of external knowledge, learning and feedback (Kline and 
Rosenberg 1986; Lundvall 1992). Currently, it has been argued that in order to compete and 
extend their core business, firms need to look outside for new knowledge and technologies 
(Chesbrough and Crowther 2006). This has become a new path towards competitive 
advantage, and is facilitated through international expansion.  
 
This view on innovation highlights that good ideas can also come from outside the 
organization (Chesbrough 2003; Chesbrough and Crowther 2006; Laursen and Salter 2006). 
This view evidently differs from earlier conceptualizations of the innovation process, where 
firms were considered as the “locus” of innovation, making their internal processes the 
determining factors (Shearmur et al. 2015). Now, although the internal capacities and 
processes of firms are still crucial, the role of external knowledge is much more recognized 
and emphasized (Lichtenthaler and Lichtenthaler 2009; Nieto and Santamaria 2007), 
significantly contributing to new knowledge in the field of innovation. Currently, external 
scientific knowledge, such as ideas and technologies, are considered a strategically 
important driver of performance that may increase a firm’s own understanding and serve as 
the initial phase for future technological developments (Arora et al. 2001; Miller et al. 2007; 
Kafouros and Buckley 2008). This new innovation paradigm, thus, becomes important in 
the link between internationalization and innovation the paper aims to explore, because now 
external knowledge is given additional weight in the innovation process. As such, there is a 
change in perception that establishes that useful knowledge is widely distributed, and firms 
must be well connected in order to identify and access it (Shearmur et al. 2015).  
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As the innovation process continues to open, intermediate markets are arising where firms 
can interact and conduct business at various stages. These were once closed and occurred 
only internally within the firm (Dahlander and Gann 2010; Huizingh 2011). According to 
Nieto and Santamaria (2007), knowledge outflows and technology exploitation lead the firm 
to leverage its existing technological capabilities beyond its boundaries. On the other hand, 
knowledge inflows and technology exploration lead the firm to capture and transform 
knowledge from external sources to modify its current technological capabilities. With the 
increasing competition in the business environment, this has become pivotal.  
 
6.4.1. Internal and external networks as sources of knowledge 
 
Supporting Cantwell’s research, MNCs are seen as systems of interdependent units with 
flows of knowledge, products, and capital (Goshal and Bartlett 1988). Interestingly, Zanfei 
(2000) views them as networks of innovators, identifying two main types of networks: an 
internal network and an external network. Within the MNC context, internal networks form 
within the headquarters and their subsidiaries, and may cover many countries. On the other 
hand, external networks form from the business links between the diverse divisions of the 
company and other independent business units.  
 
Both networks play vital roles in the knowledge transmission of the firm, and thus, have a 
direct effect on its innovation, as they can either promote knowledge – sharing or hamper it. 
Internal networks facilitate the transfer of knowledge and innovation to the company (Gupta 
and Govindarajan 2000; Frenz et al. 2005). Furthermore, Gupta and Govindarajan (2000) 
add that when local subsidiaries are given flexibility, they are able to engage in cooperative 
agreements with their environments. On the other hand, while internal networks help to 
transfer the knowledge across the firm and its different parts, external networks facilitate the 
links formed between the company and its local and foreign environments. According to 
Amara and Landry (2005), external sources can come from the market, such as clients, 
suppliers, competitors, and service firms; institutions, such as education and research 
58 
 
establishments, and public and private research laboratories and institutes; or other external 
sources, such as conferences, trade fairs, scientific journals, trade or technical publications, 
and professional and industrial associations.  
 
6.4.2. Centralized versus decentralized organizational structure 
 
The process of knowledge transfer within internal and external networks is highly influenced 
by the organizational structure adopted by firms. As such, there are conflicting views 
regarding the centralization and decentralization of firms. For example, Zanfei (2000) 
argues in his model that internal knowledge transfer is facilitated by a fairly centralized 
organization with strong central forces. This seems reasonable, as a centralized organization 
has greater internal coordination, which facilitates the information shared within the parts of 
the organization. However, this view might give for granted that this organizational structure 
does not necessarily support the external knowledge transfer of the firm. As such, the author 
states that external transfers and spillover effects are facilitated by a more decentralized 
organizational structure. This centralization – decentralization conflict has implications for 
the learning process and the spread of innovation (Frenz and Ietto-Gillies 2003), as, in the 
context of internationalization, innovation is largely dependent on knowledge.  
 
Cantwell’s (1989) perspective of innovation, in which such innovation develops and spreads 
across national boundaries, establishes that the international expansion of firms plays a vital 
role, as well as the internal networks and the integration of parts within the local 
environments in which the MNC operates (Frenz et al. 2005). An effective and consistent 
integration between the internal and external networks of firms facilitates the transfer of 
knowledge and, thus, contributes to the innovation of firms. His approach then shifts towards 
a decentralized, network – centered view of innovation development (Cantwell 1989; Frenz 
et al. 2005). In other words, particular attention is put on the integration within the group 
and the external environment, rather than on a hierarchy. Other research support this outlook. 
Goshal and Bartlett (1988) stress the importance of connections amongst the dispersed units 
of the company for innovation processes. Hedlund (1986) shifts from the traditional 
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hierarchical structure of the firm to a heterarchy. As the author establishes, this entails a 
“geographical diffusion of core strategic activities and coordinating roles”, along with a 
focus on “normative control mechanisms.”  
 
 
6.5. Overview of discussion 
 
 
From the discussion, it has been found that firms that engage in internationalization are more 
likely to innovate, mainly because their resources, products, and institutions are exposed to 
alternative innovation contexts, allowing them and their employees to learn from different 
environments (Amendola et al. 1993; Kafouros et al. 2008; Filippetti et al. 2013). 
Furthermore, having foreign operations increases investments in innovation, provides 
external knowledge sources, and allows for increased experiential learning (Hitt et al. 1997). 
In addition, internationalization presents further market opportunities for innovation (Kotabe 
1990), fosters relationship and networks (Santos et al. 2004), and allows for significant 
economic advantages (Kotabe et al. 2002; Kafouros et al 2008; Hitt et al. 1997).  
 
As has been established, knowledge plays an essential role in how internationalization drives 
innovation. Frenz and Ietto-Gillies (2005) state that having international participation allows 
for a greater development and diffusion of knowledge and innovation. Through their 
international divisions, MNCs learn from the diverse local environments, and can extend the 
innovation effects into the locations in which they operate. By expanding internationally, 
MNCs have access to unique and exclusive “bundles” of information that allow them to 
innovate through their products, processes, services, etc. Scholars have established that 
companies that operate in diverse countries learn from different innovation contexts and, 
thus, are able to benefit from them with the necessary absorptive and innovative capabilities 
(Dunning and Wymbs 1999; Castellani and Zanfei 2006; Frenz and Ietto-Gillies 2007). 
Figure 5. presents a framework that depicts the role knowledge in the process of 
internationalization as a driver of innovation. 
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Figure 5. Knowledge in the process of internationalization as a driver of innovation.  
 
The framework presented above, developed for this study, depicts the role of knowledge in 
how internationalization drives innovation. As is known from theory, through 
internationalization, MNCs have diverse international subsidiaries that interact with their 
particular geographical environments. From their access to exclusive sources of internal and 
external information, these foreign divisions develop unique knowledge, which transform 
into innovations that are transferred to the parent company and further implemented within 
the foreign subsidiaries. 
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7. RESEARCH METHODOLOGY 
 
 
This chapter presents the methodological structure of the study. Firstly, the research 
approach will be discussed. Following, the research design is presented, along with the 
research purpose and strategy. Afterwards, the data collection methods and techniques are 
explained. Finally, the credibility and ethical considerations of the paper are presented. 
 
 
7.1. Research approach 
 
 
Prior to designing the research, it is important to be clear about the research approach, which 
can be deductive or inductive. Under the deductive approach, theory is the first source of 
knowledge and deductions are built on such theory, with the aim of testing it (Saunders et 
al. 2009: 124). As established by Hyde (2000), “deductive reasoning is a theory – testing 
process which commences with an established theory or generalization, and seeks to see if 
the theory applies to specific instances.” The inductive approach, on the other hand, uses the 
empirical data collected from the research as the first source of knowledge. As such, the 
study derives from practical research, leading to formulations resulting from the data 
analysis. The main purpose of this approach is to understand what is going on, in order to 
comprehend the nature of the problem. (Saunders et al. 2009: 126). Hyde (2000) defines it 
as “a theory – building process, starting with observations of specific instances, and seeking 
to establish generalizations about the phenomenon under investigation.” It is important to 
clarify that even though the deductive approach is commonly associated with quantitative 
research, literature suggests that this is not always the case. As established by Hyde (2000), 
associating deductive approaches merely to quantitative studies “does not fully nor 
accurately describe the processes adopted by quantitative and qualitative researchers in 
practice.” The author adds that “both quantitative and qualitative researchers demonstrate 
deductive and inductive processes in their research.” Furthermore, despite the differences 
between the two approaches, they can, and should, be combined, which is why studies rarely 
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follow only one approach. As suggested by Saunders et al. (2009: 127), applying both 
approaches to the research is often advantageous. The combination of the deductive and 
inductive approaches leads to what is known as an abductive approach.  
 
For the purpose of this study, an abductive approach was adopted. This is due to the fact 
that previous theories and assumptions regarding the influence of internationalization on 
innovation have been formulated, as discussed previously in the literature review of the 
study. However, these theoretical contributions have not been examined within the particular 
industrial context of this research. As such, from the new empirical findings, the previous 
theories and models will be further explored within the research spectrum, leading to new 
empirically – based assumptions.  
 
 
7.2. Research design 
 
 
A research design is a logical and systematic plan that allows a researcher to direct a study 
(Krishnaswami and Satyaprasad 2010: 40) and go about answering the study’s research 
question(s) (Saunders et al. 2009: 136). Choosing the appropriate design and methodological 
approach to a research can be very challenging, but also extremely important, as it facilitates 
the successful development of the investigation that is being conducted. In essence, a 
research design contains clear objectives, specifies the sources of data collection, and takes 
into consideration potential constraints (e.g. access to data, time, and location) and ethical 
issues in the design, as well as the reliability and validity reasons for the choice of design 
(Saunders et al. 2009: 137). 
 
When conducting research, it is crucial to have a clear purpose of the study being conducted. 
In this way, we will know how to approach the selection of research methods and tactics. 
The purpose of the research derives from the research question(s), which will result in either 
descriptive, descriptive and explanatory, or explanatory answers. As established in literature, 
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the research purpose is mainly classified into three types: exploratory, descriptive, and 
explanatory. However, it is possible for studies to have more than one purpose. Exploratory 
studies aim at exploring “what is happening.” In this sense, they seek to understand a 
phenomena in new light and derive new, different insight. The three primary ways of 
conducting exploratory research are: searching of literature, interviewing experts, and/or 
conducting focus group interviews. On the other hand, descriptive studies provide a definite 
description of the phenomena under study, laying a foundation for the research. They do not 
often identify or correlate relationships amongst variables, but may be used as an extension 
or support of exploratory or explanatory research. As such, they are considered a means to 
an end and not an end in itself. Finally, explanatory studies seek to establish causal 
relationships between variables. Under this approach, a situation or problem is deeply 
studied, further leading to explanations of the connections between variables. (Saunders et 
al. 2009: 138 – 140). The present research follows a combination of exploratory and 
explanatory studies. The paper is exploratory because it aims to explore “what” 
internationalization and innovation mean within the MNC context and Puerto Rico’s 
pharmaceutical industry, and what are the roles they play. On the other hand, it is also 
explanatory because it seeks to understand “how” both concepts are related and “how” 
internationalization drives innovation.  
 
As data is a very broad concept, it is classified into two main types: quantitative and 
qualitative (Punch 2013: 3). According to Saunders et al. (2009: 151), the terms are used 
extensively in business and management research to differentiate between numeric or nun 
numeric data collection techniques and data analysis procedures. Differentiating between the 
two types of data is important in order to ensure the correct analysis of the evidence. 
Quantitative research is conducted mainly in the forms of surveys, mathematical modelling, 
statistical analysis, and econometrics. On the other hand, qualitative data sources come from 
observation, interviews, questionnaires, documents, texts, and the researcher’s impressions 
and reactions (Myers 2013: 7 – 8). According to the author, within business research, a 
quantitative approach is best if the researcher wants to investigate a large sample, for 
example, a particular topic across many people or many organizations (2013: 8). However, 
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a qualitative approach is the most appropriate choice if the researcher wants to study a 
particular subject more in – depth, as for example, in one or a few organizations (Myers 
2013: 9). As established by Eriksson and Kovalainen (2008: 4), qualitative research “gives 
the researcher an opportunity to focus on the complexity of business – related phenomena in 
their contexts.” This study will adopt a qualitative approach. The research focuses on 
studying how internationalization drives innovation within Puerto Rico’s pharmaceutical 
industry, selecting several key organizations and people in order to analyze such relationship 
more in – depth. Additionally, while there are theoretical contributions to how 
internationalization drives innovation topic, they are modest in amount, as literature has 
mainly focused on the influence of innovation on internationalization, and not the other way 
around. Given this analysis, qualitative data is better suited for the study.  
 
Following the identification of the research purpose and type of data, the next step in the 
research design is selecting the appropriate research strategy. While there are diverse 
strategies, some are better suited depending on certain factors. When selecting a strategy, 
Yin (1994: 4) states that the process is determined by three main conditions: the type of 
research question(s); the extent of control an investigator has over actual behavioral events; 
and the degree of focus on contemporary as opposed to historical events. Saunders et al. 
(2009: 141) add that, aside from the research question(s) and objectives, a research strategy 
will be guided by the extent of existing knowledge, the amount of time and other available 
resources, and the researcher’s own philosophical foundation. No research strategy is 
superior or inferior to any other (Saunders et al. 2009: 141). They are simply diverse 
approaches that investigators adopt in order to answer their research questions.  
 
The case study was selected as the research strategy of this paper. Eisenhardt (1989) defines 
the case study as a “research strategy which focuses on understanding the dynamics present 
within single settings.” Yin (1994: 13) states that it “investigates a contemporary 
phenomenon within its real – life context, especially when the boundaries between 
phenomenon and context are not clearly evident,” adding that multiple sources of evidence 
can be used. These sources of evidence may include interviews, observation, and 
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documentary analysis, amongst others (Eisenhardt 1989; Saunders et al. 2009: 146). It is 
argued that case studies are most appropriate when studying topics that have not yet attracted 
much previous research attention (Vissak 2010), which applies to this paper because research 
has mainly focused on innovation as a driver of internationalization, and not the other way 
around. This paper aims to study the phenomenon of internationalization and how it drives 
innovation, taking Puerto Rico’s pharmaceutical industry as the case of study. Case studies 
also allow for a multi – faceted approach to research, as they provide space for confirmatory 
(deductive) as well as explanatory (inductive) findings (Hyde 2000; Baškarada 2014), both 
of which are covered in this study under the abductive approach. Furthermore, case studies 
can include both quantitative and qualitative data, and can be based on single or multiple 
cases (Yin 1994: 14; Eisenhardt 1989).  
 
This study will adopt a multiple cases approach. The rationale behind this decision is the 
interest in identifying and exploring patterns and differences within Puerto Rico’s 
pharmaceutical industry and, subsequently, the interest in forming empirically – based 
assumptions from these findings (Saunders et al. 2009: 147). In this study, leaders from 
diverse organizations, all of which have extensive experience within the industry, took part 
of the research. This was intentionally designed in order to present diverse perspectives. In 
this study, a multiple case focus seemed more appropriate because it provides a broader view 
of how internationalization drives innovation within Puerto Rico’s industry. Moreover, case 
studies can be exploratory, descriptive, or explanatory, although they are the preferred 
method for exploratory and explanatory studies (Yin 1994: 1; Saunders et al. 2009: 146). 
Saunders et al. (2009: 146) establish that case studies provide the best contexts for 
comprehensive answers to “what?” and “how?” research questions, which represent the line 
of questioning of this study’s research: RQ 1: what do innovation and internationalization 
mean within Puerto Rico’s pharmaceutical industry?; and RQ 2: how is internationalization 
perceived to drive innovation within Puerto Rico’s pharmaceutical industry? 
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7.3. Data collection 
 
 
As previously mentioned, qualitative case studies gather data mainly from interviews, 
observation, and written documentation (Eisenhardt 1989; Saunders et al. 2009: 146). To 
generate the findings of the study, the paper conducted research through two main strategies: 
qualitative interviews and document analysis, thus adopting a multiple – methods qualitative 
approach. These comprise the primary and secondary data of the paper, respectively. While 
primary data consist of the new empirical evidence found through the direct interviews, the 
secondary data include published transcribed interviews (Saunders et al. 2009: 256).  
 
Interviews can be divided into three main types: structured interviews, semi – structured 
interviews, and unstructured or in – depth interviews (Saunders et al. 2009: 320). In 
structured interviews, researchers ask questions based on pre – determined or identical sets 
of questions. However, they are mostly used to obtain quantifiable data, for which they are 
commonly referred to as “quantitative research interviews.” As such, they will not be used 
for this study. On the other hand, in semi – structured interviews, researchers have a main 
list of themes and questions, but the selection of questions may vary from interview to 
interview. In addition, some questions may be omitted in particular interviews given a 
particular organizational context. As such, this type of interview allows for more flexibility 
regarding the interview framework. Also, in semi – structured interviews the tone is 
generally conversational and informal, and in – depth questions are also possible. Finally, 
unstructured interviews are informal, in which there are no pre – established lists of 
questions, although a clear idea about the topic to explore is needed. (Saunders et al. 2009: 
320 – 321). For the purpose of this research, a semi – structured interview approach was 
adopted, where there was a list of pre – determined questions, but these were slightly 
modified depending the position of the respondents. Additionally, the interviews evolved 
from the conversations with the participants, leading to additional in – depth questions and 
answers. Regarding the secondary data used for the study, previous transcribed interviews 
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to industry leaders were used in order to further analyze the influence of internationalization 
on innovation.  
 
7.3.1. Selection of the sample 
 
A crucial step when selecting the sample is selecting an appropriate sampling technique that 
allows the researcher to effectively answer the research questions. In this case study research, 
a non – probability sampling (non – random sampling) was selected. This type of sampling 
provides a wide range of alternative techniques to select samples based on the researcher’s 
subjective judgement (Saunders et al. 2009: 233). The specific non – probability sampling 
techniques adopted in this research were purposive and snowball sampling. Purposive 
sampling, also referred to as judgmental sampling, enables researchers to use their own 
judgement to select cases that will best allow them to answer the formulated research 
questions and to meet the established objectives (Saunders et al. 2009: 237). In other words, 
it allows researchers to actively select the most productive sample (i.e. specific respondents 
that are believed to provide the highest quality answers) (Marshall 1996). This sampling 
technique was selected because the study seeks to concentrate on people with particular 
characteristics who will be better equipped to assist and provide relevant and valuable 
information that answer the research questions. As such, in order to provide an accurate 
depiction of how internationalization drives innovation within Puerto Rico’s pharmaceutical 
industry, the participants of the study complied with certain characteristics: have vast 
experience within the industry, work for or with companies that have extensive international 
involvement, and be active leaders within the industry. In addition, the purposive sampling 
technique is commonly used when working with very small samples (Saunders et al. 2009: 
236), which applies to this study because not many firms comply with the criteria, and since 
the pharmaceutical industry is highly regulated, it is more challenging to get in contact with 
a larger sample. It is important to add, however, that the validity, understanding, and insights 
gained from data have more to do with the data collection and analysis skills of the researcher 
than with the size of the sample (Patton 2002). Within purposive sampling, there are diverse 
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strategies that can be adopted. This study used a heterogeneous sampling strategy, which 
allows for the collection of data to describe and explain themes that can be observed 
(Saunders et al 2009: 239). While the study focuses on a particular group in which the sample 
members are part of the pharmaceutical industry, they work in diverse companies, and thus 
present diverse perspectives. A weakness of the purposive technique is that it may be subject 
to bias, since the sample is selected almost entirely based on the judgment of the researcher. 
However, despite this possible partiality, purposive sampling can provide reliable and robust 
data. (Dolores and Tongco 2007). The bias will be controlled by analyzing the empirical data 
as it is offered and not providing interpretations beyond the sampled population.  
 
The snowball sampling technique was also used in this research. Snowball sampling occurs 
when respondents are obtained through the referral or identification of the original 
respondents (Saunders et al 2009: 240). While most respondents were contacted directly, 
some companies and people that were initially contacted identified further members of the 
population that they believed were better equipped to answer the questions and meet the 
study’s objectives. This technique is mostly used when it is hard to reach key people, and is 
beneficial because people are more likely to respond if they are referred to by other 
individuals they know. This allows researchers to come in contact with people that meet the 
established sample criteria. As weaknesses, Saunders et al. (2009: 240) point out that this 
technique allows for bias and the likelihood of the sample being representative is low. 
However, this study does not aim to be representative of the industry, but rather study the 
internationalization – innovation relationship as it is perceived by the respondents, and add 
to literature by shedding some new light on the subject.  
 
As mentioned, the sample that makes up this study comprises a purposive selection, 
representative of diverse leaders within Puerto Rico’s pharmaceutical industry. Due to time 
and geographical constraints, seven respondent were directly interviewed. However, their 
answers offer a comprehensive outlook of innovation and internationalization within Puerto 
Rico’s pharmaceutical industry, and how the latter is perceived to drive the former. 
Furthermore, four additional secondary transcribed interviews published on an online 
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pharmaceutical portal were also used as supplementary data in some parts of the analysis. 
Thus, a total of eleven respondents make up the sample, in order to present what innovation 
and internationalization mean to the industry, and provide an ample and contextualized 
description of how internationalization is perceived to influence innovation within Puerto 
Rico’s pharmaceutical industry. 
 
One of the criteria for the selection of respondents was that they had vast experience within 
the pharmaceutical industry, in order to be able to provide valuable insight regarding the 
influence of internationalization on innovation and the recent changes that the industry has 
experienced regarding these two concepts. Currently, much weight is being put on both 
internationalization and innovation, for which this study aimed to contact influential leaders 
that have been key in the internationalization – innovation movement within Puerto Rico’s 
pharmaceutical industry. The participants’ experience in the industry ranged from 11 to 40 
years. Another main criteria was that the firms represented by the respondents had extensive 
international participation. In the case of the consulting firms, this criteria was covered 
because they work with global MNCs, thus presenting their insights based in their 
experiences with their clients. An additional criteria was that the respondents had active 
leadership participation within the industry.  
 
7.3.2. Overview of sample  
 
As previously discussed, the empirical part of the research focuses on exploring how 
internationalization drives innovation within Puerto Rico’s pharmaceutical industry. The 
interviewed respondents were selected amongst a group of executives who are part of the 
Pharmaceutical Industry Association of Puerto Rico (PIA – PR), which gathers and 
represents research – based multinational pharmaceutical and biotechnology companies with 
operations on the Island (PIA 2015). Four of the seven direct respondents are part of the 
leadership of PIA – PR, either as part of its Board of Directors or as leading members of its 
committees. Three other respondents are partnered with PIA – PR through their Affiliate 
Membership Programme, which includes a select group of pharmaceutical industry 
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suppliers, vendors, consultants, and professionals that work along the organization. The 
respondents that make up the study occupy leading positions within their respective 
companies, ranging from Presidents, CEOs, and Executive Directors, amongst others. These 
respondents were selected because top management is naturally highly involved in the 
operations and decision – making of their companies, and thus, are most likely to have first 
– hand knowledge of the impact of internationalization on the innovation of their companies. 
In order to respect the confidentiality of the interviewed participants, their names and 
companies will be kept anonymous and will be represented by numbers and letters, 
respectively. The published transcribed interviews that make part of the findings, on the 
other hand, will include the respective references, as they are part of a series of interviews 
that were conducted to several leaders within Puerto Rico’s pharmaceutical industry on 
PharmaBoardroom, an online pharmaceutical portal. The companies represented by the 
respondents that were directly interviewed can be found in Appendix 1.  
 
The focus of the study is at an industry level. As such, the respondents of the study present 
diverse perspectives, and they have spoken based on their experiences in different 
organizations within the industry. Table 2. presents an overview of the respondents.  
 
 
Table 2. Overview of respondents interviewed.  
 
 
Title Company Position Years in 
company  
Years in 
industry 
Respondent 
1 
Company A President & CEO 18 years 23 years 
Respondent 
2 
Company B President & CEO 5 years 20 years 
Respondent 
3 
Company C Executive Director  5 years 11 years 
71 
 
Respondent 
4 
Company D President & 
General Manager 
4 years 26 years 
Respondent 
5 
Company E Legal consultant 37 years 37 years 
Respondent 
6 
Company F  President 5 years 35 years 
Respondent 
7 
Company F  Senior consultant 5 years 40 years 
 
 
As previously mentioned, several additional transcripts of interviews were also used as 
support for some of the empirical analysis of this study. These interviews were obtained 
through PharmaBoardroom, an online pharmaceutical portal which conducted a recent study 
on Puerto Rico’s pharmaceutical industry, interviewing several leaders of the industry. 
Table 3. presents an overview of the respondents of the transcribed interviews. Since these 
interviews are published in an online pharmaceutical industry portal, the information of the 
participants and companies are provided.  
 
 
Table 3. Overview of respondents of published transcribed interviews. 
 
 
Name Company Position 
Ileana Quiñones iPR – AstraZeneca, Puerto 
Rico 
President and General Manager 
Dante Castillo Haemonetics, Puerto Rico Managing Director 
Fabrice Chouraqui Novartis, Latin America and 
Canada 
President 
Andrew Wirths Merck, Puerto Rico Associate Vice President & General 
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Manager 
 
 
 
7.3.3. Structure of the interviews 
 
Due to geographical constraints, the seven primary interviews of this study were conducted 
via telephone and were recorded with the consent of the participants. They were 
administered between March and April 2016, and lasted from 30 to 60 minutes. Telephone 
interviews are quickly becoming one of the primary methods of obtaining information from 
participants in international business research (Neelankavil 2007: 214). While the absence 
of face – to – face contact does not allow for the analysis of other sources of hidden 
information, such as facial reactions and body – language, the dynamics formed with the 
respondents through the telephone provided a comfortable space that encouraged the sharing 
of valuable information and personal experiences that are believed to greatly contribute to 
the study. As such, not being able to interview face – to – face was not a limitation to obtain 
relevant data. In addition, research suggests that telephone interviews are often advantageous 
because, since respondents do not see the interviewer, they are generally more willing to 
answer confidential and more complex questions (Neelankavil 2007: 215). During the 
interviews, notes of the most important points and details were taken.  
 
In order to coordinate the interviews, prior communication was established with the 
participants and/or their administrative coordinators through emails and/or telephone calls. 
Every respondent was sent an initial email explaining the study and the reasons for their 
selection as potential participants, given their experience within the industry and their 
company’s international participation. Additionally, a resume of the interviewer was 
attached to the email in order to formalize the approach and provide a description of the 
interviewer’s academic and professional background. After a first communication was 
established and an agreement made, a date was set and the outline of the interview questions 
was sent (Appendixes 2 and 3). Following the semi – structured approach of the interviews 
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previously discussed, the question outlines varied slightly depending on the respondents’ 
positions and types of companies. The questions, while mostly the same, adapted to their 
professional contexts.  
 
Once each interview started, the interviewer formally presented herself and provided an 
additional explanation of the study and the objectives of the research. The participants were 
informed that the data would be managed confidentially and were thanked for their 
participation. Once the introduction was completed, the interviewer moved on to ask the 
interview questions. As the discussions evolved, additional questions were made in some 
cases, depending on the perceived willingness of the participant and the direction of the 
conversations. After each interview was finished, the participants were once again thanked 
for the time and valuable contribution to the study.  
 
Given that Spanish is the native language of all the participants involved, the interviews were 
conducted in such language and later translated to English by the interviewer. Despite the 
respondents having at least basic knowledge of the English language, Spanish was selected 
as the language for the interviewing process in order to respect the participants, facilitate the 
interviewing process, and encourage active and in – depth discussions. Conducting the 
interviews in English or any other language might have hampered the discussions and 
resulted in less information and/or less active participation.  
 
 
7.4. Data analysis 
 
 
The study firstly presents a theoretical review of existing literature regarding the phenomena 
of innovation and internationalization, and the relationship between the two. As established 
by Saunders et al. (2009: 490), starting from a theoretical perspective has several advantages. 
For example, it helps investigators link the research into the existing body of knowledge in 
the subject area, helps to get started, and provides an initial analytical framework. 
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Establishing a theoretical outline is extremely helpful, mainly because the extensive amount 
of information can shift the focus of the study. Further, this allows the researcher to draw 
from the theory and develop a descriptive framework.  
 
The aim of this study is to gather and further analyze new, empirical data, in order to add to 
existing literature. After obtaining the data from the interviewees, an extensive analysis was 
conducted with the purpose of studying the phenomena under new light. In order to introduce 
a clear presentation of the findings, after the extensive collection of data, the researcher 
organized it by summarizing (condensing), categorizing (grouping), and structuring 
(ordering), as suggested by literature (Saunders et al. 2009: 490).  
 
After the interviews were conducted, verbatim transcripts were made. From such 
transcriptions, the analysis began, where themes were identified according to the answers 
provided. Using the previous theoretical framework presented in the study, the answers were 
categorized and structured. For example, the literature review discussed the two most 
important elements under study: innovation and internationalization. As such, the empirical 
analysis includes what these two concepts mean within the studied industry. Furthermore, 
following the theoretical discussion regarding how internationalization drives innovation, 
the empirical analysis presents how this relationship is perceived to take place within the 
industry. Throughout the empirical discussions, the answers were grouped according to the 
themes that emerged, presenting similar and/or diverse perspectives of the topics under 
discussion, thus introducing patterns and unique findings. Direct quotations from the 
interviews were included in order to present their exact contributions and the evidence for 
the analysis.  
 
 
7.5. Credibility  
 
 
Assuring the credibility of research findings has been an ongoing research design issue 
within literature (Saunders et al. 2009: 156). According to the author, in order to reduce the 
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possibility of wrong answers and assumptions, careful attention must be given to two 
particular elements of the research design: reliability and validity.  
 
7.5.1. Validity 
 
Validity concerns the findings of the study being really what they appear to be about 
(Saunders et al. 2009: 157). In this sense, it relates to using methods that allow the researcher 
to obtain accurate data that answer the research questions and meet the study’s objectives. 
In other words, how convincing the evidence is. Yin (1994: 33 – 36) establishes that in 
empirical research, including case studies, three aspects within the standard notion of 
validity must be examined: construct validity, internal validity (for explanatory or causal 
case studies), and external validity. 
 
Construct validity is “the extent to which a measurement method accurately represents a 
construct and produces an observation distinct from that produced by a measure of another 
construct” (Baškarada 2014). As stated by Yin (1994: 37), it relates to establishing sufficient 
and correct operational measures for the concepts under study and collecting data objectively 
rather than subjectively. Simply put, it is the foundation of the research. This study seeks to 
ensure construct validity by committing to the research design, techniques and strategies 
justified in this chapter, and treating the evidence objectively, as is presented. Further, 
internal validity, which concerns only explanatory and causal studies, relates to the extent to 
which the causes of an effect are established by the research (Baškarada 2014). It concerns 
when assumptions are made regarding certain conditions that are shown to lead to other 
conditions (Yin 1994: 33). This paper aims to closely study the influence of 
internationalization as a driver of innovation. Thus, a correlation between both concepts is 
sought. However, in order to make accurate inferences about the relationship and address 
the study’s internal validity, the paper formulates correlations based on existing research and 
on the exact contributions (i.e. quotes) of the respondents. These comprise the foundation 
that support the researcher’s arguments and empirical analysis. As such, additional 
assumptions which are not supported by the data obtained are not be made. Lastly, external 
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validity relates to the extent of the generalizability of the findings. Particularly, whether the 
findings are generalizable “beyond the immediate case study” (Yin 1994: 35). This type of 
validity is a special issue within case study research, even more so if it is conducted in one 
organization or a small number of organizations (Saunders et al. 2009: 157). Case study 
samples should not be generalized to a “larger universe,” as they rely on analytical 
generalization, rather than statistical generalization, as in the case of survey research (Yin 
1994: 36). As established by the author, in analytical generalization, the researcher seeks to 
generalize a particular set of results to broader theory. As such, the purpose of case study 
research, especially those with small samples, is not to produce a theory that is generalizable 
to all populations, but to add to existing research by explaining what is going on within the 
particular research setting and identifying possible correlations with previous theoretical 
contributions (Saunders et al. 2009: 158). Thus, the findings of this research should not, and 
are not aimed to, be generalizable beyond the studied sector. They solely seek to provide 
further knowledge about how internationalization drives innovation, paying particular 
attention to a specific industrial context: Puerto Rico’s pharmaceutical sector. Additionally, 
to ensure a validity of the research, the study triangulates findings from diverse independent 
data sources (Saunders et al. 2009: 277), which explains the primary and secondary data 
used for the research. As established by Baxter and Jack (2008), “triangulation of data 
sources, data types or researchers is a primary strategy that can be used and would support 
the principle in case study research that the phenomena be viewed and explored from 
multiple perspectives.” 
 
7.5.2. Reliability 
 
Another important element concerning the credibility of research is reliability, which is 
defined as “the extent to which a measurement process produces similar results on repeated 
observations of the same condition or event” (Baškarada 2014). In other words, it relates to 
maintaining consistency in the operations of a study, such as the processes of collecting and 
analyzing data, in order to ensure that if the processes are repeated on the same case and 
under the same conditions, they would produce the same results. The goal is to minimize 
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errors and biases (Yin 1994: 36). The author establishes that in order to ensure the reliability 
of case studies, researchers should thoroughly document the research procedures followed. 
This study has done so by discussing in detail the research techniques and data collection 
methods, as well as the justifications for those choices. Additionally, in order to ensure the 
reliability and truthfulness of the data provided by the interviewees, these were informed 
that their contributions were confidential, thus encouraging the sharing of accurate 
information. Further, before conducting the interviews, the participants were sent emails 
with descriptions of the study and the aim of the interviews. As such, they agreed to 
participate only if they were knowledgeable on the subject and were able to provide reliable 
information. Also, during the interviews, clarifications were made if there were any 
questions left unclear, enhancing their understanding of the issues being presented.   
 
 
7.6. Ethics 
 
 
Ethics in research concerns the researcher’s moral standards of conduct in relation to the 
moral entitlements of the people who are subject of the research or are in any way affected 
by it (Saunders et al. 2009: 183). In other words, respecting the rights of those who 
participate in the study and avoiding doing any harm. According to Orb et al. (2001), the 
nature of ethical issues within qualitative resort is different than that of quantitative research, 
as potential problems in qualitative studies often concern how the researcher gains access to 
a group and the effects the researcher may have on the participants. Thus, researchers must 
ensure that the way the research is designed is “both methodologically sound and morally 
defensible to all those who are involved” (Saunders et al. 2009: 184). Additionally, the 
participating organizations and respondents have the right to expect quality research which 
takes account of existing knowledge (Saunders et al. 2009: 187). Thus, as a researcher in 
business, there is a responsibility to analyze and report the data gathered in all accuracy and 
veracity, as they were originally provided by the participants. This was achieved by basing 
the findings and arguments on the exact contributions gained through the primary and 
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secondary data sources (i.e. direct interviews and transcribed interviews). Furthermore, in 
order to comply with the ethical commitment of the paper, the confidentiality of the 
participants was respected, and the interviews and data collection only proceeded if there 
was absolute consent, deriving from the voluntary nature of the respondents (Saunders et al. 
2009: 185). In addition, the paper applied ethical measures throughout the research by 
appropriately making reference to all the previous studies that were used to support the study.  
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8. EMPIRICAL FINDINGS AND DATA ANALYSIS 
 
 
This chapter presents and analyzes the findings of the interviews conducted for this case 
study. This empirical analysis aims to provide a comprehensive depiction of what innovation 
and internationalization mean to diverse leaders within the pharmaceutical industry in Puerto 
Rico, and explain how internationalization is perceived to drive innovation within the 
industry. Thus, following the empirical research objectives and theoretical background of 
the study, this chapter presents the data obtained, with the aim of answering the research 
questions.  
 
The chapter is divided into three main sections. The first and second sections will discuss 
the concepts of innovation and internationalization, respectively, from the diverse 
perspectives of the participants. As such, this covers the first research question of the study 
(RQ 1: What do innovation and internationalization mean within Puerto Rico’s 
pharmaceutical industry?). Given that both topics are the main concepts under study in this 
paper, studying them within the particular context of Puerto Rico’s pharmaceutical industry 
will provide existing literature with a unique perspective of their importance within the field 
of international business. The third section will present how internationalization is perceived 
as a driver of innovation within Puerto Rico’s pharmaceutical industry, leading to the second 
research question of this study (RQ 2: How is internationalization perceived to drive 
innovation within Puerto Rico’s pharmaceutical industry?).  
 
 
8.1. Innovation within the pharmaceutical industry  
 
 
As discussed in the literature review of this research, innovation is as a “multistage process 
whereby organizations transform ideas into new/improved products/services or processes, 
in order to advance, compete and differentiate themselves successfully in their marketplace” 
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(Baregheh et al.  2009). It can take diverse forms, yet the consistent variables are novelty 
and/or improvement. Innovation has been a recurring topic within the pharmaceutical 
industry, made evident through the empirical data gathered. As established by Petrova (2014: 
20), “the pharmaceutical industry is essentially defined by innovation.” The author argues 
that scientific research, the creation of new knowledge bases, the invention of new 
medications, and the improvement of existing drugs, embody the fuel that drives the firms 
within such industry.  
 
In order to follow a structure that propels the understanding of how internationalization 
drives innovation, it is important to first comprehend what innovation represents to diverse 
leaders within Puerto Rico’s pharmaceutical industry. As such, the participants of the study 
were asked to explain what innovation meant to them, and how important they believe it is 
for the industry. Further in the chapter, the diverse types of innovations considered in 
literature are discussed, as well as the strategies associated with innovation. In order to 
present a broader picture of innovation within the industry and provide additional support to 
the empirical findings, several perspectives of other leaders within Puerto Rico’s 
pharmaceutical industry obtained through published transcribed interviews are also 
presented. 
 
8.1.1. Meaning of innovation 
 
The empirical data gathered support the theoretical notion that innovation concerns creating 
new things or doing things in different ways, and the ability to adapt to changes (Kanter 
1984: 20). As Respondent 1 states, innovation has two slopes: doing new things or finding 
ways of changing them and making them better. In other words, creating or making 
improvements that make the company more efficient in its processes, services, etc. In terms 
of adapting to changes, it is interesting to see how Company A has complied with the 
industrial changes by identifying opportunities and adapting their organizational framework 
to the business models of their clients, in order to meet and supply their needs. According to 
Pisano (2015), business model innovation has become very relevant in recent years, which 
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is the case for Company A, as their complete operational approach is constantly being 
modified in order to stay competitive and up – to – date with the industry. The company has 
also incorporated technology as a main source of innovation, which has propelled the 
efficiency of their systems and, thus, organization. As Pisano (2015) establishes, 
technological innovation has historically been an essential creator of economic value and a 
pivotal driver of competitive advantage. Respondent 1 highly values what the company calls 
“mini-innovations.” 
 
“Innovation has two sides: do new things or do existing things in different ways. For 
me, perhaps the greatest innovation we do in the company is the way we work business 
models [...] That for us is an innovation. On the other hand, we can have a 
performance evaluation and then modify it, or we want to do something new or to 
change it, and that it is also an innovation because we are continually changing for 
the better [...] its doing the same thing differently. Those are basically the two ways, 
but they are key because they are the way you revive the company, how you keep it 
alive and well, and also keep it attending the new modalities that are emerging [...] 
Another fundamental element is technology. The way technology evolves lets you do 
things that maybe you could not do before, and you can do what you were doing but 
differently.” 
(Respondent 1, Company A) 
 
Respondent 2 also supports the notion of innovation as novelty, as it is “all that has not been 
done.” The respondent adds to this perception by establishing that in Company B, innovation 
is applied mainly to how their services are delivered. Furthermore, and particularly 
interesting, in Company B, innovation does not only concern creating new things, but also 
offering the same services to a wider range of people. In this sense, novelty is applied to how 
they deliver their services and the reach of those services. This presents an interesting 
contribution to the research, as there is an important relationship between 
internationalization and innovation. In this sense, it can be argued that internationalization 
is considered a type of innovation, because to the extent that the company reaches larger 
markets, they are innovating. Respondent 2 states that innovation plays an essential role 
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within the industry, as the advancements achieved through pharma have changed the world’s 
development. 
 
“Innovation is all that has not been done, taking into consideration that we are not 
only referring to products, but also services, and that we are referring [...]  to a service 
that had not been provided before in a specific market or region. [...] Innovation is 
something that not only moves the industry, but that has been moving the world. [...] 
The world would not have been able to develop without the new knowledge and the 
new medical applications that we have had.” 
(Respondent 2, Company B) 
 
Respondent 7 also supports the view that innovation comprises new changes and 
improvements. Additionally, technology has an important role within the innovative 
technologies that are developed. 
 
“One could think that there is an innovation where you take existing processes and 
improve them, making substantial changes to improve the performance, lower the cost, 
or to eliminate problems that they cause. [...] The industry we represent is based on 
innovation, it is constantly looking not only for new products, but also new 
technologies and new methods to make the products.” 
(Respondent 7, Company F) 
 
Furthermore, Respondent 5 also supports the previous contributions by establishing that 
innovation concerns doing new things (“inventing”) or improving them (“reinventing”). 
Interestingly, the respondent adds that innovation can take place either proactively or 
reactively. In other words, that it can adopt either a leading role within the industry or a 
follower approach, reacting to the changes in the industry. In addition, the respondent 
recognized the crucial role of innovation within the pharmaceutical industry, as it is a 
fundamental element that supports production and how all the processes take place. The 
respondent also takes into account the innovative capacity of firms (IC), previously 
discussed in the study. The capacity to innovate is essential because it “contributes directly 
to innovation by allowing for the identification and translation of external knowledge 
inflows into tangible benefits for the firm” (Shearmur et al. 2015). As such, being able to 
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respond to the market changes and use the information available to innovate is of crucial 
importance for the pharmaceutical industry. Given this, an initial link between innovation 
and the importance of external knowledge can be identified.  
 
“For me, innovation is to invent/reinvent, either proactively or reactively, products, 
processes, structures, and ways of doing business. Innovation is of vital importance 
for the pharmaceutical industry. This industry depends on having a flow of products, 
a market for its products, and competitive costs of production and sales. These are 
changing factors that require the industry to have innovative capacity.”    
(Respondent 5, Company E) 
 
Furthermore, for AstraZeneca, innovation can have diverse meanings, but in essence it 
comprises novelty in the sense that it involves doing things differently, which has also been 
supported by the findings presented above. For the company, technology is an essential part 
of the innovations that take place within the organization, as in Company B. These 
technologies support the efficiency of their Puerto Rican site.  
 
“...innovation can mean many things. AstraZeneca innovates by finding ways to do 
things differently, such as gaining in efficiency or implementing better technologies. 
Some of this is being done here in Puerto Rico at this site, implementing those 
technologies as part of manufacturing.” 
(Ileana Quiñones, President and General Manager, iPR – AstraZeneca, Puerto Rico) 
 
Respondent 4 provides an intriguing contribution to the concept of innovation, as the novelty 
intrinsically related to it is developed in order to create value. As established by Pisano 
(2015), companies have to select the types of innovation that will allow them to create and 
capture the most value. As such, creating value can be regarded as the essence and main aim 
of innovation. In this sense, companies implement innovations in order to increase the ways 
in which they create and deliver value, both within their companies and to their global 
clients. Another important finding regarding innovation concerns the importance of creating 
collaborative environments that allow for further and more encompassing developments in 
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research, thus leading to higher innovation levels. Hence, integration amongst diverse 
players is pivotal in order to achieve significant levels of innovation.  
 
“To me, innovation is creating a new product, process, or service that benefits people 
and businesses and creates value. [...] Within our industry, I believe it is crucial for 
companies to not only create innovation through their own R&D groups, but to also 
collaborate with partners both within and outside the industry.  An open research 
environment creates new possibilities for all of us. By breaking through barriers and 
working collaboratively with others, we can more quickly deliver the next generation 
of medicines to the patients who need them.” 
(Respondent 4, Company D) 
 
This collaborative approach is supported by Novartis, a company that seeks to make sure 
that their innovations are available to every eligible patients around the world. This presents 
a very interesting contribution about the importance of innovation within the pharmaceutical 
industry in Puerto Rico. The company values innovation to the extent that it aims to make 
sure that such innovations are made available to every eligible patient. Essential components 
in order to achieve this is communication and an integrative framework between the diverse 
sectors that have an effect on the industry, including political players. Thus, as also 
established by Respondent 3 (Company C), country – level innovation has an effect on 
industry – level innovation. This is also supported by Respondent 4 (Company D), who 
believes it is essential to collaborate with diverse sectors in order to develop further 
innovations. Working alone is not sufficient.   
 
“... we ought to work with public and private players to ensure that access to 
innovation is not only reserved to those who can afford it. All eligible patients need to 
be able to access this innovation. This will require innovative thinking, more 
sophisticated approaches from all parties and an open dialogue in how we can work 
together to address the needs of these patients.” 
(Fabrice Chouraqui, President of Novartis Latin America and Canada) 
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Moreover, Respondent 6 presents an engrossing contribution by stating that an important 
aspect of innovation is being able to make the innovative idea a reality. Thus, it is essential 
that an innovation is feasible. Further, the respondent places special attention on innovation 
within the pharmaceutical industry by expressing that it is the essence of the industry, its 
“reason of being.” The advances that have been developed over time are what have propelled 
the industry’s growth and importance. Additionally, a proactive approach to innovation is 
also presented.  
 
“For me, innovation is finding a different solution to fulfill, satisfy or create a need, 
and make it viable. I think that a key element in order for an idea to stop being good 
and become a real innovation is that it translates into some result or that it can be 
implemented. ... At a macro level, of the industry, innovation is the reason of being, 
because this industry is based on [...] finding solutions to improve a health condition, 
[...] or to extend the life of a person, and in some cases to eradicate a health problem.” 
(Respondent 6, Company F) 
 
Additionally, for Haemonetics, innovation is directly related to the clients, who have 
diverse expectations about their products and services across the globe. While there may 
be common market expectations, companies within the industry succeed when they 
innovate by recognizing the existing differences and adapting to their markets, as 
previously discussed in literature (Kanter 1984: 20). As such, a client – focused 
innovative approach is presented, where being able to anticipate, understand and cater to 
the specific needs of clients is crucial.   
 
“For us innovation is about anticipating, listening, understanding and striving to 
fulfilling and exceeding our customer expectations, recognizing that expectations can 
vary from one market to another.”  
(Dante Castillo, Managing Director, Haemonetics, Puerto Rico) 
 
From the discussion, it can be indrawn that innovation plays an essential role within the 
pharmaceutical industry, given its need to continuously develop and implement the best and 
most effective products, processes, and services for their clients and patients. While 
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respondents expressed their views of innovation in slightly different ways, an identified 
pattern is that innovation regards creating new things (novelty) and/or developing new ways 
of doing things (improvements), as supported by theory (Kanter 1984: 20; Oslo Manual 
2005). Additional insights make interesting contributions regarding innovation within Puerto 
Rico’s particular pharmaceutical industry, mainly: the important role of technology in the 
process of developing and executing innovations; the relevance of creating collaborative 
environments where diverse players contribute to the creation of innovations; the importance 
of adapting to markets and meeting needs and expectations. Furthermore, the perception of 
value as the main aim of innovation is notable, as well as the importance of developing 
innovative capabilities that allow companies within the industry to make innovations 
feasible.  
 
8.1.2. Types of innovations 
 
Regarding the types of innovations adopted within Puerto Rico’s pharmaceutical industry, a 
combined approach was identified, as supported by Respondents 4 and 5. 
 
“[...] we drive innovation across many facets of our business.”   
(Respondent 4, Company D) 
 
“In Puerto Rico, innovation has to do with a combination of types of innovation.” 
(Respondent 5, Company E) 
 
From the perceptions of the sample, it can be drawn that, within Puerto Rico’s 
pharmaceutical industry, process, product, and organizational innovations are prevalent. 
These are commonly combined in order to support a comprehensive organizational approach 
to innovation. As established by Fillipetti et al. (2013), different innovation types are 
interconnected and complementary. Thus, their combination has a positive impact on 
performance.  
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Company A focuses on process and organizational innovation, while in Company C, 
product and process innovation play a major role, but organizational innovation is also 
adopted. On the other hand, Company F identified a closer approach to process innovation, 
although product and organizational innovation is also present.  
 
“Process innovation, things we did in a certain way and now do in another because 
of the new tools we have to do them. [...] The organizational paradigm innovation, the 
organizational methods, of performance evaluation [...] redo it, change it.” 
(Respondent 1, Company A) 
 
“I think it is a combination. [...] Products and process innovations. The organizational 
methods are also something that we are constantly changing. We are always looking 
for the most effective ways to operate.”   
(Respondent 3, Company C) 
 
“It is mainly process innovation, although there could some related to products and 
also some related to organizational paradigm. In fact, in Puerto Rico, many 
companies have done many interesting things in terms of their organizational 
structures.” 
(Respondent 7, Company F) 
 
It was identified, however, that position (marketing) innovation is less common within the 
pharmaceutical industry. Notwithstanding, Respondent 3 recognized that it is also important 
in order to achieve the company’s objectives. The respondent established that the operational 
flexibility of the plant supports the marketing groups, who develop innovations within their 
departments with the information they receive.   
 
“In terms of marketing innovation, we do not talk much about it within the industry, 
but we do work very closely with our colleagues of what we call the “commercial 
side,” in order to support their needs.” 
(Respondent 3, Company C) 
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Respondent 2 presents an interesting contribution, establishing that in Company B, 
innovation is implemented to services, and not so much emphasis is placed on products or 
processes. As such, they seek to incorporate innovation in the ways they provide their 
services to their global customers. From the discussion, it was inferred that 
internationalization within the company is itself seen as a type of innovation, because for the 
company, to the extent that they offer their existing services to new people, they are 
innovating. 
 
“For us, innovation is based on innovation in services. There are services that we have 
provided for a long time to the United States’ market, which we are now starting to 
provide to Latin America, and even though it is nothing new for the North American 
market, it represents an innovation for the Latin American market.” 
 
Given the findings, innovation takes diverse forms, as supported by literature (Francis and 
Bessant 2005; Bessant and Tidd 2007: 13), and a combination of innovations is often 
beneficial (Fillipetti et al. 2013). Regardless of these classifications, however, research 
suggests that innovation types are interdependent (Wischnevsky et al. 2011). For this reason, 
the process innovations carried out within the industry, affect product and organizational 
innovation, and so on. Process innovation was the most common type of innovation 
identified within the sample, which can due to the fact that the pharmaceutical industry is 
highly ... However, product and organizational innovation were also considered crucial, 
especially in recent years, when many pharmaceutical companies have had to undergone 
transformational organizational changes.  
 
8.1.3. Innovation strategies 
 
Given the data obtained from the sample regarding the innovation strategies adopted within 
the pharmaceutical industry in Puerto Rico, it could be identified that innovation is carried 
out through diverse strategies, which vary depending on the context to which they are 
applied. This is supported by literature, as different kinds of innovation can be 
complementary (Pisano 2015). Generally, though, innovation follows an incremental 
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approach within companies. However, in certain areas of the industry, radical and/or 
disruptive strategies are better suitable.  
As stated by Respondent 5, within the industry, the innovation strategies adopted are varied. 
For example, when a product is first introduced to a market, a radical innovation takes place. 
However, the improvements that are made on such product follow an incremental innovation 
approach. 
 
“Innovation in the pharmaceutical industry is not limited to one type. When a brand 
new product is introduced, innovation is radical. When improving an existing product, 
innovation is incremental.” 
(Respondent 5, Company E) 
 
Respondent 2 states that Company B has adopted an incremental approach to innovation. 
The company has grown as their resources and opportunities have allowed them to, 
implementing small, gradual innovations that have supported their development within the 
industry. 
 
“It would be incremental. We were founded as a single – person company, and the 
company has grown from there [...] and the company has renewed itself as the market 
has presented opportunities. [...] Everything has happened in an incremental way, as 
the company has developed the structure and resources to do it and have growth.” 
(Respondent 2, Company B) 
 
In the same way, Respondent 6 states that incremental innovation is the most common 
strategy within Puerto Rico’s manufacturing facilities. However, at a macro level, of the 
industry as a whole, innovation takes on a disruptive approach, as new innovations are being 
developed for conditions that do not have solutions. 
 
“In manufacturing, the innovation that is done is mostly incremental. At a macro level, 
of the industry, it is definitely disruptive because finding a solution to a heath condition 
that does not have an available therapy is obviously disruptive. At a manufacturing 
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level, however, in Puerto Rico and in other parts of the world, it is mainly 
incremental.” 
(Respondent 6, Company F) 
 
Similarly, Respondent 1 established that in Company A, innovation is usually carried out 
incrementally. However, the innovation that relates to the clients has recently adopted a 
disruptive approach. This presents an interesting angle, because the company has had to 
differentiate between the innovations strategies that better adapt to the diverse parts of the 
firm. It was identified during the interview that due to high regulations, the pharmaceutical 
industry mainly follows an incremental innovation path. As such, a gradual approach to 
innovation is generally the most suitable. However, changing customer needs allow for, and 
often require, more intense innovation strategies, since business models are changing. 
 
“My clients are manufacturing companies that have been doing things in one way 
their whole lives. Now, they are outsourcing, and you begin to become part of their 
department. That kind of partnering is quite disruptive. That's why it takes so long to 
implement, and even more so because my clients are in a regulated industry. 
Pharmaceuticals are the last ones to do disruptive things.” 
(Respondent 1, Company A) 
 
Finally, Respondent 7 establishes that often times, innovations require a radical approach in 
order to obtain better results. However, the respondent states that within Puerto Rico’s 
manufacturing sector, incremental innovation is the overall strategy of innovation.   
 
“I had many experiences where we had a process that we had tried to improve 
gradually, but there came a time where it was necessary to make substantial changes. 
[...] It is mainly incremental, but in the fundamental side, of the development of new 
products, it is disruptive or radical.” 
(Respondent 7, Company F) 
 
From the findings, thus, it could be argued that during the creation of the products (macro – 
industry level), a radical approach is adopted, since they are being developed for conditions 
that often do not have treatments. However, once those treatments and drugs have been 
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approved and are supplied to the markets (micro – level), they go through continuous 
improvements, thus following an incremental approach.  
 
8.1.4. Summary 
 
From the discussion, it becomes evident that innovation plays a critical role within Puerto 
Rico’s pharmaceutical industry. The constant global challenges, as well as international 
competition, have made innovation fundamental. In addition, it can be inferred that, given 
the scientific nature of the industry, innovation is ingrained within it, as scientific 
developments are in constant advancements of new and innovative pharmaceutical 
treatments.  
 
As can be derived from the previous discussion, innovation within the industry has two 
slopes: novelty and gradual improvements, as proposed by literature (Kanter 1984: 20; 
Baregheh et al.  2009). An interesting finding obtained from the data is that the degree of 
such novelty depends on the company’s strategic objectives, and that novelty itself can be 
said to encompass the concept of improvement, because these incremental advances also rely 
on new ways of doing things. In addition, from the findings it can be drawn that novelty can 
regard deep – seated and unique creations, or also new ways in which the services are 
delivered or the geographical reach of such services. This presents an interesting connection 
between innovation and internationalization, because internationalization itself is sometimes 
considered an innovation depending on the company’s aims.  
 
Something that has been identified is that diverse innovation types are adopted within the 
industry. While process innovation seems to be the most common type of innovation adopted 
within the sample, companies combine it with product and organizational innovations as 
well. This supports literature, as it is common for companies to adopt a combined approach 
to innovation (Wischnevsky et al. 2011). Further, innovation also takes diverse forms within 
the industry. Innovation occurs mostly in an incremental way, particularly from a 
manufacturing perspective. However, a radical and/or disruptive strategy, especially in the 
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phase of product development, is also present. In this sense, while some areas of a business 
survive on gradual innovations, others depend on radical innovations, such as business 
model changes.  
 
 
8.2. Internationalization within the pharmaceutical industry 
 
 
Within the context of business, internationalization regards opening up to new foreign 
markets. As discussed, the continuous development of the current global economy has led 
to an increasingly interrelated business world, which has attributed much pertinence to the 
phenomenon of internationalization (Wattanasupachoke 2002; Rogers 2004). Thus, after 
exploring the concept of innovation from the perspectives of diverse leaders within Puerto 
Rico’s pharmaceutical industry, it becomes important to also present what 
internationalization means to them. As such, this section discusses what internationalization 
represents to the studied sample, including the motives for engaging in internationalization 
within the pharmaceutical industry and the general internationalization approaches adopted.  
 
8.2.1. Meaning of internationalization 
 
As stated by Hitt et al. (1994), internationalization relates to “expanding across country 
borders into geographical locations that are new to the firms.” While this is sustained by 
other scholars (Ruzzier et al. 2006), Respondent 2 adds a very interesting contribution to 
theory, stating that internationalization is not only entering different countries, but also 
assimilating the culture and different markets of the foreign countries. In essence, that a real 
immersion in such countries is important. Interestingly, Respondent 3 goes along the same 
line, establishing that internationalization goes beyond regular global expansion. It concerns 
making that global expansion as consistent as if the company was working within the same 
country. Throughout the interviews, both respondents pointed out the importance of acting 
globally, but thinking locally. In the same way, Respondent 4 also regard internationalization 
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as a process where it is important to take into consideration the country and culture. These 
present very interesting and thought – provoking findings, as internationalization involves 
more than just the establishment of operations overseas, but an exhaustive immersion of the 
company into the country and culture. It can be argued, thus, that internationalization within 
Puerto Rico’s pharmaceutical industry considers specific market factors, going beyond the 
traditional theoretical descriptions discussed in the paper.   
 
“[...] internationalization does not only relate to providing services in different 
countries, but accepting and adapting to cultures and markets in different countries. 
[...]We like to use the term “glocal.” It is offering services in the most global way 
possible, but offering them with a local footprint. [...] In essence, internationalization 
means that a company becomes recognized as a company of the country or region in 
which it operates, although everyone recognizes that it has an experience and 
background that it has imported from other places.” 
(Respondent 2, Company B) 
 
“[...] internationalization is the capacity to being able to work at a global level with 
all the countries in the world as if they were local. [...] I could be embarking to 100 
countries in the world, and that for me is global expansion, but internationalization 
for me goes a bit further: it is making such global expansion as if I was working with 
neighboring countries or within the same country.” 
(Respondent 3, Company C) 
 
“The term “internationalization” to me is taking a product or service to global 
markets and ensuring the successful use within that local country and culture.” 
(Respondent 4, Company D) 
 
Another interesting finding regards the adoption of internationalization in order to achieve 
strategic objectives. As discussed in theory, internationalization has recently become an 
important business strategy (Sdiri and Ayadi 2014). This is the case for Company A, because 
internationalization is a way for the company to achieve its strategic goal of creating closer 
relationships with their clients, no matter where they are located geographically. 
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“For me, it is the fundamental element of our business strategy [...] In essence, our 
strategic objective is to stay within the same pharmaceutical segment [...] so it is not 
regional. For me, it didn’t matter where we were [...] because it is the way that I can 
serve a client with different plants around the world, and intimate more with them.” 
(Respondent 1, Company A) 
 
Moreover, from the standing point of the pharmaceutical cluster as a whole, Respondents 5 
and 7 agree that multinationality is very important for the industry. In fact, Respondent 7 
states that the industry is international by nature, with companies having substantial 
international participation, as supported by research (ABPI 2016). According to Respondent 
5, such multinationality gives companies access to information, which is particularly 
relevant within the context of this study, as current theory focuses on internal and external 
sources of information and knowledge as one of the main ways in which internationalization 
drives innovation, as will be discussed further in the paper.  
 
“The pharmaceutical industry in Puerto Rico is part of a multinational industry [...] 
Being multinational is very important for this industry. This gives you access to 
information and flexibility to locate and/or move legal entities and/or production from 
one country to another.” 
(Respondent 5, Company E) 
 
“We are talking about multinational corporations, so naturally they are already 
internationalized. The pharmaceutical industry is globally integrated. [...] From 
Puerto Rico, we send products to at least 100 countries. This is a completely 
international industry [...] global by design.” 
(Respondent 7, Company F) 
 
From the discussion, it can be drawn that internationalization is an integral part of the 
pharmaceutical industry. While it regards the expansion to new markets, internationalization 
within Puerto Rico’s pharmaceutical industry takes a further meaning, identifying the need 
of adapting to the foreign markets. As such, internationalization covers a broader definition 
than the traditional global expansion view present in literature (Hitt et al. 1994; Ruzzier et 
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al. 2006). Additionally, internationalization is also often implemented as a strategic 
objective, because given the global nature of the industry, being present where clients are 
located is essential. Further, and particularly relevant, internationalization is perceived to 
give access to unique information and flexibility not available otherwise.  
 
8.2.2. Internationalization motives and market selection  
 
As established by Yip (1989), there are four main drivers that motivate 
internationalization, these being: market, cost, government, and competitive drivers. 
From the discussions, it was noted that within the industry, some companies’ 
internationalization was/is mainly influenced by market drivers, namely global customers 
and contacts within the foreign markets. In the case of Company A, Respondent 1 stated 
that the company established operations abroad primarily motivated by the localization 
of their global clients, who facilitated their localization in the foreign markets. The 
decision to internationalize, being a strategic objective of the company, was done in order 
to achieve their competitive differentiator, which is to have close and long – term 
relationships with their clients, wherever they are located. In the same way, Respondent 
2 established that Company B decided to internationalize due to constant requests from 
their global clients. As such, both companies expanded operations where they already had 
existing clients. In this sense, the selection of countries was based on market needs (i.e. 
needs of their clients). Additionally, in both cases, their global clients and established 
global networks within the markets presented significant advantages in terms of the 
facilitation and successful establishment of their foreign operations, as supported by 
literature (Madsen and Servais 1997). The internationalization of Company D presents a 
similar scenario, where the company has expanded operations in order to be able to 
provide their products to their customers around the globe. The locations of their 
international operations have been based on strategic locations that allows them to reach 
them more easily.  
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“My clients are multinationals [...] In order for us to achieve our differentiator, 
customer intimacy, we have to be able to serve our clients, wherever they are. We 
have positioned ourselves where they have their operations. [...] They were also 
the ones that facilitated the process. [...] We established in the countries mainly 
because of the customers.” 
(Respondent 1, Company A) 
 
“Some of our clients told us: ‘If you are doing this for me here and I am satisfied 
with your work, why not do is in other places as well. If I have found the partner 
with whom I feel comfortable, I want to replicate this success in other places’.” 
(Respondent 2, Company B) 
 
“As a global, science – led company, [company] seeks to make our medicines 
available to patients globally.  In order to ensure the products are available to specific 
regions and markets, it may require investing in a presence in a specific region, 
country, etc. This could help to facilitate many aspects of the business, such as product 
registration and approval, manufacturing, or marketing.” 
(Respondent 4, Company D) 
 
Furthermore, a combination of competitive, cost, and government drivers were also 
identified within the sample. Pharmaceutical companies expand in order to increase sales, 
but there are also other economic motivators that influence how internationalization takes 
place. For example, during the interviews, it was stated that companies that have greater 
international participation, lead the industry. Moreover, in the particular case of Puerto Rico 
as a global pharmaceutical attraction, public policy measures, such as generous tax and 
economic incentives, have been some of the main reasons for expansion to the country, 
according to the participants of the study. This is also the case with Ireland, for example, 
who offers significant economic incentives and tax benefits for foreign companies to 
establish operations, which is one of the reason Companies A and B expanded there. 
Additionally, an interesting finding that derived from the discussions was that Puerto Rico’s 
extensive pharmaceutical industry experience, the high academic preparation of its habitants, 
and the overall quality of the human capital also act as main drivers for industrial players to 
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expand to the country. In essence, the knowledge and experience that has been developed 
within the jurisdiction.  
 
“We seek to expand sales internationally because it obviously translates into more 
dollars, more income generation. [...] In terms of expanding to Puerto Rico [...] our 
jurisdiction is still the most attractive in the world to conduct operations of the 
pharmaceutical industry. This is due to the financial incentives that Puerto Rico 
offers.”  
(Respondent 3, Company C) 
 
 “The treatment of income for federal tax purposes is one of the determining factors. 
Other important factors are [...] facilities, infrastructure, and human capital.” 
(Respondent 5, Company E) 
 
“The tax incentives program for R&D is really good and this is also available for 
services and manufacturing.” 
(Dante Castillo, Haemonetics) 
 
“I would say that it is definitely related to costs, competitiveness, to public policy [...] 
but in this industry there is also a very strong driver that is related to knowledge. The 
knowledge factor becomes key within the industry. [...] So, I would say costs and 
competitiveness, but I would add knowledge.” 
(Respondent 6, Company F) 
 
“One of the drivers is how to capture a more ample participation of the global market. 
Obviously, the companies that participate the most in international markets, will have 
more catch of that participation.” 
(Respondent 7, Company F) 
 
Given the findings, in terms of entry strategies, the location component seems to be the most 
relevant within Puerto Rico’s pharmaceutical context. Virtually, cost and tax factors (tax 
rates and investment incentives), strategic factors (strength of the existing manufacturing 
activities, the industrial connections, the workforce productivity, and the inbound and 
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outbound logistics), and regulatory and economic factors (industrial policies and FDI 
policies), as established by literature (Luo 2002: 181- 190).  
 
8.2.3. Internationalization process 
 
As previously discussed in literature, innovation can be linked to internationalization 
through a stages models approach, where internationalization is seen as a cautious and 
progressive process (Murray and Ron 2010). From the perceptions of the studied sample, 
internationalization within Puerto Rico’s pharmaceutical industry follows an incremental 
approach.  
 
Companies 1 and 2 stated following a gradual approach to innovation, driven by the market 
insights gained throughout the process. Interestingly, Company 3 also experienced a gradual 
process during the initial stages of operations.  
 
“Our internationalization process was very gradual. [...] It takes a lot of time, because 
at the same time, you also have to make sure that you provide the same level of service 
to clients. There has to be a lot of consistency. [...] It takes a lot of time being able to 
escalate in a sustainable way, while controlling the experience of the brand.” 
(Respondent 1, Company A) 
 
“I would say that from a certain point, it has been gradual. [...]of course it depends 
on what one compares it to, but our internationalization process began in 2006. [...] 
Back then the company was thirteen years old [...] it has taken us ten years and we 
are still working on it.” 
(Respondent 2, Company B) 
 
“During the first twenty or twenty – five years, the internationalization was gradual. 
... That changed, and in the last ten years, the internationalization has been much 
faster. ... From Puerto Rico, we now export to one hundred countries, compared to 
twenty – five, ten years ago..” 
(Respondent 3, Company C) 
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From the empirical data, it can be argued that a gradual approach to internationalization 
within the pharmaceutical industry is related to the stage in which the company finds itself. 
In other words, a gradual approach to internationalization is often adopted in the initial 
phases of companies. For example, within Companies 1 and 2, an incremental approach to 
internationalization has been adopted, resulting from the opportunities that have risen from 
their incremental foreign operations and the learnings that have resulted from them. This can 
be justified given that they are relatively young companies. In the same way, Company 3 
experienced a gradual internationalization growth within the first twenty – five years of 
operations. Within their Puerto Rican division, their expansion has only recently experienced 
a faster pace of global growth, increasing from twenty – five countries of reach, to over one 
hundred in the last ten years. An interesting contribution to the stages models is that a gradual 
approach to internationalization may allow for more consistency in the level of service 
provided across the globe, as can be inferred from Respondent 1’s answer. It can be argued, 
thus, that a gradual approach provides space for gradual learning, hence allowing for a 
deeper understanding of each market.  
 
From the findings, it can be argued that the U – Model of internationalization has been 
applied, where internationalization develops as changes and advances occur within 
companies and their environments (i.e. new challenges and opportunities) (Johanson and 
Wiedersheim – Paul 1975). In essence, the companies have internationalized following 
logical steps based on a gradual gain of information, acquired from their foreign markets and 
operations. Additionally, as stated by Carneiro et al. (2008), the U – Model establishes that 
firms first internationalize to psychically close countries and gradually move to more distant 
markets. This is certainly the case of Companies 1 and 2, for example. The former first 
expanded to the United States, developing connections and opening offices in several states, 
later expanding to Europe. The latter also followed this behavior, as the company initially 
opened offices in the United States, and further expanded to Europe and South America. 
Furthermore, another interesting approach to the stages models of internationalization is 
proposed by the I – Models, previously discussed. The I – Models that most relate to the 
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studied sample are Cavusgil’s (1980) and Reid’s (1981), in which firms are interested in 
international participation form early stages. For example, Company 1 indicated that 
internationalization was a strategic objective of the company, for which the firm always 
aimed at expansion. Given the global nature of the industry, it can be argued that a vast 
majority of companies present interest in international growth from early stages, as was the 
case of the sample.  
 
Moreover, according to the findings, networks play a very important role when it comes to 
the first step towards internationalization to a new market, following the network theory 
previously discussed. This is supported by literature, as the updated version of the U – Model 
(Johanson and Vahlne 2009) argues the importance of the network theory, which called for 
changes in the original U – Model. Now, it is believed that business relationships have a 
significant impact on the markets firms decide to enter. As established by Madsen and 
Servais (1997), it is through relationships that firms gain access to external resources that 
allow them to establish themselves successfully in foreign markets. As was discussed in the 
previous sub section, client networks and contacts within the markets of interest facilitated 
and had a considerable influence on the internationalization of Companies 1 and 2. From 
those initial relationships, other relationships formed, which, at the same time, grew into 
further opportunities. As argued in the theoretical part of the research, building networks and 
relationships with customers is extremely important in global business settings, because 
these mutual relationships allow for better results in the internationalization process, 
reducing liability of foreignness.  
 
8.3.4. Summary  
 
From the data, it was found that internationalization within Puerto Rico’s pharmaceutical 
industry gains a broader meaning than that discusses commonly in theory. Expanding across 
national borders is considered global expansion, while internationalization adds to such 
global expansion by considering specific characteristics of the global markets, in order to be 
able to adapt to them. It was also found that the pharmaceutical industry as a whole is 
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extremely integrated and global, for which internationalization is a natural and essential part 
of it.  As stated by Respondent 7, it is “global by design.” Given this multinational industrial 
phenomenon, companies have larger access to broader sources of information, which can 
support their operations. In addition, it was found that market drivers, mainly global clients, 
are the main motivators for expanding operations abroad, as within a number of the sample, 
internationalization was motivated by the localization of other pharmaceutical clients. These 
clients and networks facilitated their internationalization process, as proposed by literature. 
Moreover, a combination of other competitive, cost, and government drivers were also 
considered to motivate internationalization. Puerto Rico, for example, presents many tax 
benefits for global pharmaceuticals companies, explaining their strong presence in the 
country. However, it was also found that aside from these traditional motivators established 
by literature, the knowledge and industry experience of Puerto Rico were also highly valued 
as motivators for establishment in the country. Amongst the sample, a stages approach to 
internationalization was identified, with gradual and incremental steps leading the way to 
global expansion. As such, the U – Model and I – Models were identified. However, from 
the findings, it was argued that an incremental approach to internationalization can be related 
to the phase in which the company finds itself. Mainly, it was found that in the initial steps 
towards internationalization, a gradual approach is adopted, but after a solid establishment, 
a more rapid process takes place.   
 
 
8.3. Internationalization as a driver of innovation 
 
 
After answering RQ 1 (What do innovation and internationalization mean within Puerto 
Rico’s pharmaceutical industry?), the following section answers RQ 2 of this study: How is 
internationalization perceived to drive innovation within Puerto Rico’s pharmaceutical 
industry? In order to do so, the respondents’ views on this relationship are presented and 
discussed. 
 
 
102 
 
8.3.1. Relationship 
 
At a macro – industry level, Respondent 2 presents an interesting perspective. In Company 
B, internationalization drives innovation by allowing for further flexibility in the processes 
the company develops in order to reach and adapt to their international markets. In other 
words, internationalization has driven its innovative approach when developing methods that 
allow it to provide the same consistent level of services, in a different way to their global 
clients. This has developed an innovative expertise within the company, which, according to 
the respondent, can only be achieved through internationalization.  
 
“I believe internationalization increases innovation. [...] Independently if the service 
you provide is good [...] in order to provide that service in another country, you need 
to adapt to the country. [...] In the end, it is the same services experience we provide 
in Puerto Rico, but provided to the client in a different way. We have had to develop 
methods, an internal method of how to do them and how to develop those projects [...] 
While maintaining a consistency in the experience the client seeks, we have had to 
learn to deliver the services in a different way. [...] And that occurs because we have 
internationalized.” 
(Respondent 2, Company B) 
 
Similarly, Respondent 3 established that internationalization has driven the innovation of the 
company’s whole supply chain, given their need to expand globally. As such, they have 
tailored their supply chain in order to better reach and adapt to their markets, and ensure 
higher degrees of efficiency and global extent. In this sense, internationalization has driven 
innovation within the company by acquiring an innovative approach to how their whole 
operational chain is managed.  
 
“[...] internationalization has been the driver of innovation from the point of view of 
the supply chain. [...] All of its customization has been motivated by the need of 
expanding internationally.” 
(Respondent 3, Company C) 
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In both cases, the perceptions of how internationalization drives innovation are directly 
related to adapting to markets. As such, it can be inferred that internationalization allows for 
greater foreign contact, leading to customized innovative approaches to global markets. 
 
Respondent 7 provides support from a different angle, establishing that internationalization 
drives innovation because it forces companies to meet diverse market needs. In this sense, 
internationalization forces companies to innovate because diverse markets presents distinct 
needs and require different approaches. Thus, in order to survive competition in 
international, innovation is pivotal. 
 
“Internationalization forces to satisfy different markets, different needs, and there has 
to be innovation.” 
(Respondent 7, Company F) 
 
Moreover, an important finding that derived from the data is that of knowledge as an 
essential element within Puerto Rico’s pharmaceutical industry. For example, in the process 
of product production, there has been a shift towards obtaining knowledge, as stated in one 
of the transcribed interviews of this study. It is through such knowledge that products 
undergo further improvements throughout their life cycles.   
 
“What has changed is the idea of placing knowledge at the front end, building the 
knowledge as the product matures.” 
(Andrew Wirths, Merck, Puerto Rico) 
 
This finding becomes particularly relevant within this paper’s theoretical discussion, as 
knowledge has often been regarded as key in the relationship between internationalization 
and innovation (Hitt et al. 1997). Interestingly, it has been identified that, related to 
knowledge, internationalization drives innovation within the industry in two particular ways: 
it provides higher visibility at a macro – industry level, leading to the implementation of 
competitive innovative practices; and it facilitates how knowledge, both developed 
internally and obtained externally, is shared across the company through its international 
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divisions, also leading to higher degrees of innovation. An important aspect of this 
discussion is knowledge – sharing, as will be further presented.   
 
As discussed in literature, when a company engages in international operations, it has access 
to unique sources of information that can develop into competitive knowledge for the firm, 
which can be used to increase innovation within the company through its diverse 
international divisions, as summarized in Figure 5. As previously discussed, from their 
learnings of their environments, international divisions increase the innovation scope within 
the company as a whole. As such, through high degrees of interactions with their diverse 
geographical contexts, firms are able to further develop their innovative performances. As 
supported by several other scholars, the unique knowledge developed, as well as the ability 
to create and transfer it across foreign divisions, is considered a strategic asset (Nonaka and 
Takeuchi 1995; Bierly and Chakrabarti 1996; Spender 1996; Teece 1998). This is the case 
in Puerto Rico’s pharmaceutical industry. At a macro – industry level, internationalization 
is perceived to drive innovation by allowing for higher visibility regarding industry standards 
across global jurisdictions, thus enhancing the competitive advantages of companies. 
Respondent 1 suggests that internationalization drives innovation by allowing companies to 
see what is being done across the industry in diverse pharmaceutical clusters, like Ireland or 
the United States, for example. By doing so, they are able to learn about the innovative 
practices that are being conducted abroad, and implement the innovations that best serve 
them. As the respondent states, it leads to benchmarking, which allows them to compare 
themselves to industrial standards. The respondent also adds that internationalization allows 
companies to receive feedback about their practices by sharing them across their 
international divisions, thus providing space for improvement. Additionally, the company 
has found that, often times, international clients have motivated their innovation by sharing 
their own innovative practices, which the company has later implemented to its global 
offices. As can be drawn, knowledge sharing has been key.  
 
“Internationalization increases the experience of your processes and their feedback 
loop, so you can improve them. At the same time, it increases your reach of seeing 
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what is happening in the world, in the industry. I can see something in Ireland which 
is good, and then I implement it in Puerto Rico, or I can be doing something in the 
United States and they ask me: “but why are you not doing it this way?,” and then I 
start doing it another way and implement it to the other offices. For my clients it is 
also fascinating, because when they implement an innovation [...] they already know 
that we can implement it in their other locations [...] Internationalization is 
fundamental in order to be connected to the world and know what is happening and 
the best practices. That is, the benchmark.” 
(Respondent 1, Company A) 
 
Respondent 3 provides support to this by stating that internationalization allows companies 
to see what other players within the industry in other jurisdictions are doing. This provides 
space for them to adopt greater innovative practices that enhance their competitive 
capabilities.  
 
To the extent that you go to other jurisdictions and are capable of identifying what 
they are good or better at, and you copy it, or you use it to influence your own 
innovation.” 
(Respondent 3, Company C) 
 
Along the same line, Respondent 4 makes another important contribution, stating that 
knowledge sharing across global regions allows the company to gain information prior to 
entering a market. In this sense, global knowledge sharing influences the ways in which the 
company can innovate in order to reach those markets.  
 
“Within a large, global company, it is important to understand the markets, and 
influences within those markets, before creating a presence and doing business. By 
utilizing external and internal knowledge and experience, you can ensure better 
decision – making and business planning.  With continuous knowledge sharing among 
global regions, along with a culture of innovation, you can inspire increased 
innovation.” 
(Respondent 4, Company D) 
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Furthermore, internationalization is also perceived to drive innovation by facilitating how 
knowledge is developed and dispersed within companies through their global operations. As 
stated by Respondent 5, internationalization drives innovation within the pharmaceutical 
industry by simplifying how knowledge and resources circulate across the industry. At a 
company level, the knowledge that is developed in one facility, can be shared with another. 
In this knowledge – sharing process, the international divisions of a company benefit from 
the innovations developed in other global branches. In this way, the innovations that best 
support the company can be implemented across the global operations. According to 
Respondent 5, given that pharmaceutical companies often have centralized structures, the 
parent company gathers the information and then disperses the knowledge within its 
international divisions. As supported by theory, both sources of information play vital roles 
in the knowledge transmission of the firm, having a direct effect on its innovation. As 
previously discussed, while internal networks propel the transfer the knowledge across the 
company and its international divisions, external networks assists the progress of the links 
formed between the company and its foreign environments (Gupta and Govindarajan 2000; 
Frenz et al. 2005; Amara and Landry 2005). Another interesting contribution made by the 
respondent is that this knowledge flow can also occur at an employee level, where managers 
are located in diverse international facilities where they able to learn from other ways of 
doing things, while also implementing the innovative practices that are carried out in his/her 
home division. This regards experiential knowledge, discussed in the U – Model (Johanson 
and Vahlne 1977). As established, experiential knowledge provides managers and 
employees with a broader background to perceive and formulate real opportunities, which 
plays a key role in the internationalization of firms, because such knowledge can be 
transferred and, thus, drive innovation across the whole company.  
 
“Internationalization facilitates the flow of knowledge and resources. This occurs, for 
example, with the central structure of the matrix, which collects internal information 
(from its subsidiaries in different countries) and external (from other companies and 
countries) and then spreads it across its subsidiaries in several countries [...] It also 
occurs at the individual level, with the movement of management from one country to 
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another. In this industry, it is common for a manager to have job assignments of one, 
two, three years in facilities in the United States, South America, Europe, and Asia.” 
(Respondent 5, Company E) 
 
Respondents 6 and 7 provide support, establishing that, in essence, internationalization 
drives innovation through the learning and sharing of knowledge carried out across the 
international divisions of pharmaceutical companies. Both respondents emphasize that 
within this particular industry, since many products are made in different locations, the 
diverse facilities are able to learn from each other. For example, Respondent 6 states that 
from a manufacturing perspective, there are often global teams within a company’s 
international network, whose main objective are to constantly share the innovations that are 
being developed. In this sense, the innovations that are developed in one country and/or 
operational division, are shared with the rest of the network. Respondent 7 supports this by 
asserting that within the pharmaceutical industry, the fact that the same products are made 
in diverse parts of the world leads to innovation because divisions are constantly 
communicating and sharing the advancements within their products and processes.  
 
“Internationalization definitely has an effect on innovation, because, from a basic 
manufacturing perspective, for example, you have global networks of manufacturing, 
and there could be a product that is manufactured in different locations around the 
world, and through the participation of global teams, the rest of the network can gain 
knowledge over how it is innovating another part of the operation and apply that 
innovation within its own facility. [...] If Puerto Rico innovates to improve a part of 
the process, other countries benefit from that innovation. The same happens when 
other countries innovate. I think that is one of the ways in which being multinational 
helps to innovate and multiply the benefit of the innovation.” 
(Respondent 6, Company F) 
 
“A phenomenon that happens within this particular industry is the fact that many 
products are produced in so many different countries, which can help innovation [...] 
In one of the companies in which I worked, we had three facilities in three different 
countries in which we made the same product. [...] all the facilities were given the 
opportunity of developing innovations, but they were asked to share the knowledge 
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acquired. Many processes were significantly improved due to the interaction within 
those three district facilities, working on and sharing their innovations.” 
(Respondent 7, Company F) 
 
Along the same line, Respondent 4 also provides support to the role of knowledge as a 
particularly important element in the studied internationalization – innovation relationship. 
In the case of Company D, the respondent establishes that internationalization drives 
innovation through their global research and development. The international reach of their 
research cluster has led to advancements in their discoveries and developments of innovative 
treatments that are improving patients’ lives around the world. In this sense, innovation takes 
a deeper scientific approach, and internationalization enhances the developments that arise 
from the research conducted in the company’s diverse international divisions. As such, the 
knowledge developed across its international clusters has greatly influenced the innovations 
that the company has developed over time.  
 
“As a global, biopharmaceutical company [...] we have Clinical Research and 
Development happening simultaneously around the world. This has allowed 
advancements in our science, disease knowledge, and experience with new therapies 
to increase, while also allowing for the development of innovative treatments that are 
saving lives and improving the quality of life for global patients.” 
(Respondent 4, Company D) 
 
Given the findings, the framework presented in Figure 5. was revised in order to illustrate 
how knowledge is developed and transferred within this study’s particular context. Within 
Puerto Rico’s pharmaceutical industry, internationalization facilitates how foreign 
subsidiaries share and develop further knowledge amongst themselves. They do not work 
independently from each other, but instead constantly communicate and share knowledge 
through active internal global networks and teams. Through these networks, they share 
existing innovative practices and develop new ones, and also create further knowledge 
resulting from their collaborations, which translate into innovations that are transferred to 
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the parent companies. The parent companies gather the innovations and implement them 
throughout all their foreign divisions, and the cycle continues.  
 
In essence, the framework supports the one developed from the theoretical findings, but 
much more emphasis is placed at the subsidiary level in terms of how innovative knowledge 
is created and shared. Previous theory focus on the external environments from which 
subsidiaries learn and gain knowledge, but within the studied sample, the focus is primarily 
placed on the internal networks. These are crucial for innovation, because from increased 
global collaborations, further innovations within the industry are created. Another important 
element in how knowledge is transferred within the industry is through the rotation of 
employees across their international divisions, as supported by literature. The revised 
framework is presented in Figure 6.  
 
 
 
Figure 6. Knowledge in the process of internationalization as a driver of innovation within 
Puerto Rico’s pharmaceutical industry. 
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8.3.2. Summary 
 
Within Puerto Rico’s pharmaceutical industry, internationalization is perceived to drive 
innovation in various ways. It can be inferred from the findings and discussion that, in a 
central way, internationalization drives innovation by forcing companies to adapt to diverse 
markets. In other words, global markets require different approaches, for which companies 
are in need of developing innovations in order to survive. As such, it can be argued that 
innovation is inherent to internationalization within the pharmaceutical industry, because in 
such a science – led industry, companies are in need of constantly searching for the best and 
most effective practices that allow them to expand their geographical reach. Furthermore, 
knowledge is believed to play an essential role in the relationship between 
internationalization and innovation. As was found, at a macro – industry level, 
internationalization allows companies to have further industrial visibility, through which 
they are able to gain unique and exclusive insights about better industry practices, which 
leads to higher innovation. In this sense, it allows companies to compare themselves to other 
players and adopt innovative practices that enhance their competitive advantages. On the 
other hand, and particularly relevant, at an internal – company level, internationalization 
propels knowledge sharing across subsidiaries, leading to further innovative advancements. 
Within Puerto Rico’s pharmaceutical industry, such knowledge – sharing takes place 
through global networks and teams, and the international rotation of employees.  
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9. CONCLUSIONS 
 
 
Based on the theoretical and empirical discussions of the research, this chapter presents the 
conclusions of the study. The theoretical contributions and managerial implications are 
presented, along with the limitations of the study and suggestions for further research.  
 
 
9.1. Theoretical contributions 
 
 
This study makes a contribution to current literature within the field of international business 
by broadening the existing understanding of how internationalization drives innovation, 
shedding new light on the relationship by studying how this process takes place within the 
context of Puerto Rico’s pharmaceutical industry. The concepts of innovation and 
internationalization have been thoroughly explored, leading to an explanation of how the 
latter drives the former. From the empirical findings and analysis, internationalization is 
perceived as a driver of innovation. Interestingly, many of the findings were supported by 
previous literature. However, there are also several interesting contributions. From the study, 
it was found that innovation and internationalization are at the core of Puerto Rico’s 
pharmaceutical industry. As a science – led industry, innovation is intrinsic to the sector, 
leading to significant advances in the treatments and medications that have saved the lives 
of millions of patients worldwide. As such, innovation is deeply ingrained within 
pharmaceutical operations across companies. In the same way, the pharmaceutical industry 
is global by nature, with companies increasingly expanding to diverse markets.  
 
The study’s empirical data present several interesting findings regarding how 
internationalization drives innovation within the studied industry. Theory has proposed that 
innovation in general takes two forms in terms of nature and degree: incremental and radical 
(Dewar and Dutton 1986; Orlikowski 1991; Bessant and Tidd 2007: 14). An interesting 
finding is that within the context of the study, an incremental approach to innovation was 
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prevalent, even though the pharmaceutical industry is commonly known for developing 
world – changing medical treatments. While these innovations make up an essential part of 
the industry’s innovative behavior, in Puerto Rico, incremental innovations are more 
common. This could be due to high regulations across the industry and to the fact that most 
pharmaceutical players in the country are subsidiaries of foreign MNCs. In the case of local 
MNCs within the industry, the approach to innovation is similar, with an incremental 
innovative behavior prevailing. As such, within Puerto Rico’s pharmaceutical industry, 
innovation generally takes place through gradual improvements, which are achieved through 
high degrees of knowledge – sharing, feedback, and industrial benchmarking. Given this 
gradual approach to innovation, it has been inferred that internationalization drives 
innovation within Puerto Rico’s pharmaceutical in an incremental way as well. In this sense, 
the information gained through their global participation leads mainly to gradual 
improvements in the products and services, naturally leading to incremental innovations. 
 
Furthermore, the study make a contribution to current literature by broadening the meaning 
of internationalization. While existent literature refers to the concept as a process through 
which companies expand across national borders, within Puerto Rico’s pharmaceutical 
industry, the term gains a broader meaning. Given the diversity of health needs across the 
globe, companies have had to develop extensive international capabilities that allow them to 
meet such needs in specific geographical contexts. In this sense, it was found that 
internationalization goes beyond the phenomenon of global expansion, because an integral 
part of this expansion is being able to assess the characteristics of each market. Particularly, 
internationalization within the studied context regards reaching foreign markets, but with a 
local approach and while maintaining a global consistency in services.  This, in itself, can 
be inferred to lead to the development of innovative capabilities that allow companies to 
successfully enter and excel in such markets. As can be drawn, internationalization covers a 
wider theoretical spectrum, gaining an added value through innovation. Related to this, it 
has been found that internationalization drives innovation within Puerto Rico’s 
pharmaceutical industry by driving competition. In other words, internationalization 
obligates companies to develop and adopt innovations that allow them to enter and succeed 
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within their markets. In this way, it can be said that innovation naturally results from 
internationalization because, due to global expansion, companies are in need of developing 
innovations that allow them to remain competitive. As such, international expansion within 
the industry allows companies to continue developing their innovations. 
 
Finally, as a science – led industry, it was found that knowledge plays a pivotal role in how 
internationalization drives innovation within Puerto Rico’s pharmaceutical industry, 
supporting the KBV discussed in literature. At an internal – company level, one of the main 
findings of this study regards the importance of internal networks, not only because they 
ease knowledge transfer, but because through active collaborations within international 
subsidiaries, higher degrees of innovation can be achieved. While previous research focuses 
on the learnings subsidiaries gain from their external environments and later transfer to the 
parent companies, the findings of this study suggest that significant weight is placed on 
subsidiary team – work, in the aim towards innovation. These collaborations are driven by 
global networks and teams, which actively work together to communicate the best practices 
and develop further and advanced innovations. As such, in the process of achieving 
innovation through internationalization within the pharmaceutical industry, significant 
importance is placed at an internal – company level, where the knowledge developed and 
shared amongst subsidiaries is crucial. From this analysis, it can be further inferred that such 
active, internal knowledge transfers between subsidiaries undermine the possible limitations 
presented by the KBV. As previously discussed, Shearmur et al. (2015) establish that even 
though companies can open themselves to foreign markets, they may not always be able to 
appropriate all the information and knowledge to which they have access. However, it can 
be argued that the diverse, strong global networks present within the pharmaceutical industry 
strengthen the capacities of companies to absorb, assimilate, and transfer information, and 
further develop innovations. In other words, through constant global collaborations, it can 
be argued that companies highly strengthen their innovative capabilities.  
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9.2. Managerial implications 
 
 
The findings discussed in this research present several important managerial implications 
that can represent significant contributions to current international business practice. First 
and foremost, while it has been suggested that global participation facilitates how 
information is reached, this study has found that, by actively working together through global 
networks and teams, subsidiaries can become even higher sources of competitive advantages 
for firms. As such, MNCs should consider the added value that is created when their 
subsidiaries create networks that constantly work together in the development of new and 
innovative practices. By developing such global teams, companies will have better 
opportunities of increasing both the innovations that make them more efficient internally, 
and the innovations that are developed for their markets. Hence, this evidences the 
importance of developing solid internal knowledge – sharing platforms within MNCs, which 
further develop the capabilities necessary to absorb and transform external information into 
unique knowledge that is translated into innovations.  
 
In addition, this empirical study suggests that internationalization requires more than just 
geographical expansion. As such, it is important for MNCs to consider other cultural and 
market – specific factors that might affect their establishment, especially within the 
pharmaceutical industry, where innovations are always emerging, leading to higher 
competition. Moreover, it has been shown that in the process of internationalization, clients 
and networks are key, particularly within highly regulated industries. Most times, as drawn 
from the findings, companies start internationalizing because of client requests. As such, it 
remains pivotal for MNCs to continuously develop and nourish their networks and 
relationships, as they often facilitate how companies enter and succeed in foreign markets.  
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9.3. Limitations 
 
 
As has been addressed previously in the study, limitations may be present in research. In the 
case of this paper, several limitations have been identified, which should be taken into 
consideration upon further analyzing the study’s findings and contributions to current 
research. In terms of the sample, the size of such cannot and is not aimed at being 
representative of the whole pharmaceutical industry. It simply offers a context – specific 
analysis that provides diverse perceptions from several leaders within Puerto Rico’s 
pharmaceutical cluster. Related to such generalizability, a qualitative approach to research, 
particularly in terms of external validity, is limited. Due to mainly focusing on a particular 
geographical context where participants share similar characteristics, it is often difficult to 
generalize to a larger population. (Myers 2013: 9.) This has been particularly true for case 
studies, which have been previously criticized due to their limitations when trying to 
generalize findings. Often times, researchers try to select large cases with the aim of 
providing a “representative” sample of the context under study. However, no set of cases, 
regardless of their size, is likely to be completely representative of the population. Instead, 
the focus should be on generalizing findings to theory (Yin 1994: 37). For this reason, the 
findings of this study should not be applied to any context outside the studied sample, 
including other global clusters of the pharmaceutical industry, other industries, or other 
company types. The study’s aim is not to generalize, but instead to provide a rich and 
contextualized depiction of how internationalization is perceived to drive innovation within 
Puerto Rico’s pharmaceutical industry. As such, the study cannot provide interpretations 
beyond the sampled population. To address other particular contexts, further research should 
be conducted. Additionally, the purposive and snowball sampling techniques give space to 
bias, as the participants present similar characteristics. However, they were the sampling 
techniques that allowed for the identification and selection of the most knowledgeable 
participants for the study.  
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In terms of the interviewing process, a possible limitation is that, due to geographical 
constraints, the interviews were conducted via telephone, which could be argued to take 
away the value of face – to – face contact. In addition, the interviews were conducted in 
Spanish, and were later translated into English. The researcher has full bilingual proficiency. 
However, in research it might be possible for some loss in meanings through translation.  
 
 
9.4. Suggestions for future research 
 
 
In order to address the aforementioned limitations and enhance existing knowledge 
concerning how internationalization drives innovation, further research should be conducted 
within multiple industrial contexts. Exploring how internationalization influences 
innovation within other industries would provide more ample insight, resulting in further 
support and/or additional findings of how the process takes place. By conducting multi – 
industrial studies, further inferences could be made regarding patterns or differences 
amongst industries, leading to more exhaustive knowledge. Furthermore, to enhance the 
investigation within the pharmaceutical industry, an additional suggestion for further 
research regards conducting the study within a wider sample, including managers and 
employees who have had extensive international assignments, as well as suppliers and locals 
from the foreign markets. This would allow research to gain other varied perspectives of 
how internationalization is perceived to drive innovation within other contexts. Studying the 
phenomena within a larger sample would present better possibilities of being representative 
of how internationalization drives innovation. In addition, given how the pharmaceutical 
industry is highly internationalized, it would also be beneficial to conduct the study within 
the diverse pharmaceutical clusters around the world. Moreover, it would be useful for 
current research to approach the investigation quantitatively, in order to provide a numerical 
and economic analysis of how internationalization influences the innovative performance of 
firms. Mainly, to investigate the economic effects of such relationship and provide 
quantitative support.  
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APPENDIX 1. Company profiles.  
 
COMPANY 
COUNTRY 
OF 
ORIGIN 
YEAR 
FOUNDED 
INTERNATIONAL 
PRESENCE 
COMPANY PROFILE 
Company A Puerto Rico 1997 North America, 
Europe 
Provides control systems, instrumentation, and regulatory 
compliance services to the biotechnology and pharmaceutical 
sectors, and has incorporated innovation as one of its most 
important corporate values. Since its foundation, the company 
has achieved significant global presence, initially expanding to 
the United States, and subsequently to the United Kingdom and 
Ireland. In such countries, they respond to the needs of their 
biopharmaceutical multinational clients in their demands for 
the consistent implementation of their automation and 
regulatory compliance solutions. 
Company B Puerto Rico 1993 North America, 
South America & 
Europe 
Services the pharmaceutical industry, growing to be one of the 
largest regulatory compliance and validation companies in the 
world. The company has experienced exponential international 
growth in a relatively short period of time, initiating its global 
presence with a project in Italy and later in the United States. 
Subsequently, it became a registered company in the United 
States, later expanding its operations to Ireland, and afterwards 
to Spain and Brazil. The company is well – established in both 
eastern and western Unites States and Europe, with diverse 
offices within such regions, and services a wider range of 
countries from their Caribbean, North American, South 
America, and European offices. 
Company C United 
States 
1980 100 + countries 
It is one of the world’s leading and largest biotechnology 
companies, with presence in more than 100 countries and a 
reach of millions of people in the fight against serious illnesses. 
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The company is centered on a culture that embraces science 
and innovation, which has led to the successful launch of some 
of the industry’s pioneering therapeutics, changing the course 
of the pharmaceutical industry and, subsequently, medicine. 
Their main objective is to discover, develop, manufacture, and 
deliver innovative medicines that help patients with serious 
illnesses. 
Company D Britain - 
Sweden 
1999 100 + countries 
Global, science – led biopharmaceutical company whose 
innovative medicines are used by millions of patients 
worldwide. The company combines a unique range of 
knowledge, skills and experience to lead innovation in science. 
Their research sites focus on collaborations, innovations, and 
dynamic environments that allow them to keep developing 
further advancements.   
Company  E Puerto Rico 1933 Services MNCs in 
Puerto Rico 
Legal firm servicing the pharmaceutical industry in Puerto 
Rico, forefront of the needs of their clients growing and 
adapting as they require. 
Company F Puerto Rico 2011 Services MNCs in 
Puerto Rico 
Consulting and advisory services to the pharmaceutical 
industry in Puerto Rico. Consultants have extensive 
backgrounds working as managers and executives at diverse 
MNCs in Puerto Rico and abroad.  
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APPENDIX 2.  
INTERVIEW QUESTIONS TO MANAGERS 
Questions: 
1. How would you define innovation? How important is it for [company] and the 
pharmaceutical industry? 
 
2. [The company’s] innovation relates more to which of the following types? Please 
explain. 
 
a. Product innovation  
b. Process innovation 
c. Paradigm innovation (organizational methods) 
d. Position innovation (marketing) 
e. Combination   
f. Other 
 
3. Has [company] adopted a “radical”, “incremental” or “disruptive” innovation strategy?  
 
4. How would you define internationalization? How important is it for [company] and the 
pharmaceutical industry? 
 
5. The academic literature establishes that there are certain “drivers” that impulse 
internationalization. These can be related to costs, markets, public policies and/or 
competitiveness. In [the company’s] internationalization, which do you think were the 
principal motives for which it decided to expand operations?  
 
6. What factors determined the selection of the countries to which [the company] has 
expanded?  
 
7. Was [the company’s] internationalization gradual (incremental) or fast (progressive)?  
 
8. Do you think internationalization drives innovation? If so, how?  
 
9. Much of the existing literature establishes that a way in which internationalization drives 
innovation is by providing and/or facilitating external knowledge (from the diverse 
markets) which can be applied within the company to increase its innovation. Based on 
your experience, is this true?  
 
10. How does information flow within the international divisions of [the company]? Do you 
think that the organizational structure (centralized or decentralized) of the company 
influences how this knowledge is used?   
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11. How does [the company’s] Puerto Rican division benefit from the knowledge the 
company obtains from its diverse international markets?  
 
12. What do you think are the biggest challenges when managing international operations? 
How has [company] been able to overcome them?  
 
 
Thank you very much for your time and contribution! 
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APPENDIX 3.  
INTERVIEW QUESTIONS TO CONSULTANTS  
Questions: 
1. How would you define innovation? How important is it the pharmaceutical industry? 
 
2. In Puerto Rico, innovation relates more to which of the following types? Please explain. 
 
a. Product innovation  
b. Process innovation 
c. Paradigm innovation (organizational methods) 
d. Position innovation (marketing) 
e. Combination   
f. Other 
 
3. Based on your experience, do you think companies within Puerto Rico’s pharmaceutical 
industry adopt/have adopted a “radical”, “incremental” or “disruptive” innovation 
strategy?  
 
4. How would you define internationalization? How important is it for the pharmaceutical 
industry? 
 
5. The academic literature establishes that there are certain “drivers” that impulse 
internationalization. These can be related to costs, markets, public policies and/or 
competitiveness. Within industry’s internationalization, which do you think were the 
principal motives for which it decided to expand operations?  
 
6. What factors are determinant upon the selection of the countries to which companies 
expand?  
 
7. How are companies able to obtain initial information about the markets to which they 
want to expand? Do they have networks in such markets?   
 
8. Do you think internationalization drives innovation? If so, how has this process taken 
place within Puerto Rico’s pharmaceutical industry?  
 
9. Much of the existing literature establishes that a way in which internationalization drives 
innovation is by providing and/or facilitating external knowledge (from the diverse 
markets) which can be applied within the company to increase its innovation. Based on 
your experience, is this true?  
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10. Do you think that the organizational structures (centralized or decentralized) of 
companies have an effect on how this knowledge is taken advantage of?  
 
a. ¿How does Puerto Rico benefit from the knowledge its companies obtain in other 
international markets?  
 
11. What do you think are the biggest challenges when managing international operations? 
 
12. What efforts are being carried out in the country in order to continue internationalizing 
Puerto Rico’s pharmaceutical industry?  
 
 
Thank you very much for your time and contribution! 
 
 
 
